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CHAPTER I 
 
INTRODUCTION 
 
Cell Motility and Migration 
Cell migration is a tightly regulated process central to a number of 
biological functions and pathological conditions. For example, wound healing is 
dependent upon migration of fibroblasts and vascular endothelial cells; 
leukocytes migrate into injured areas to mediate an immune response; and in 
cancer metastasis, tumor cells migrate from the original tumor site into the blood 
vessels, and then back out of the vasculature and into a new location to form 
secondary tumors (Lauffenburger and Horwitz 1996). Cells migrate on an 
extracellular matrix (ECM) in a repetitive, four-step mechanical process 
(Lauffenburger and Horwitz 1996). The process begins with the extension of a 
broad lamellipodial protrusion, thought to be driven by actin polymerization 
(Wang 1985; Carson, Weber et al. 1986; Borisy and Svitkina 2000). The signals 
for actin assembly at the leading edge are generated by components of the ECM 
such as fibronectin (Fn) and various growth factors. Stabilization of the protrusion 
occurs by formation of multiple small adhesions that increase in size, 
organization and strength. This lends traction against the ECM to propel the cell 
body in sustained migration (Beningo, Dembo et al. 2001; Zaidel-Bar, Ballestrem 
et al. 2003). The constant assembly and disassembly, or turnover, of nascent  
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Figure 1. Cell Migration is a four-step mechanical process. Cell 
migration begins with the extension of a lamellipodial protrusion (1) followed by 
stabilization of the protrusion by the formation of adhesions between the cell 
membrane and the ECM (2). (3) The cell body then translocates in the direction 
of the protrusion and (4) the rear of the cell retracts and detaches from the ECM. 
Adapted from (Lodish, Berk et al. 2000). 
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cell-matrix adhesions within the leading edge protrusion is essential for 
continuous migration (Webb, Donais et al. 2004). Finally, net displacement of the 
cell occurs when adhesions at the trailing edge disassemble and release the 
substrate (Fig 1.) (Horwitz and Parsons 1999). Failure to establish adhesions at 
the leading edge leads to lamellipodial ruffling, an inefficient attachment to the 
ECM (Borm, Requardt et al. 2005). Failure to disassemble adhesions rapidly 
prevents the cell from disengaging the ECM, and therefore delays or disrupts the 
migration process. Each step of the migration process must therefore be 
stringently controlled for proper function. 
 
Actin Cytoskeleton 
 
Branched Actin of the Lamellipodium 
 Motile cells have a very thin leading lamellum, a sheet-like protrusion densely 
filled with actin filaments (Abraham, Krishnamurthi et al. 1999; Pollard and Borisy 
2003). Actin is the most abundant protein in many eukaryotic cells, and by mass, 
filamentous actin (F-actin) is the dominant structural component of the 
lamellipodium. Filaments are made up of polymers of globular actin (G-actin) 
monomers, arranged in a helical structure with the monomers in a head-to-tail, 
polarized arrangement. This molecular polarity is key to the mechanism of actin 
assembly in cells (Pollard and Borisy 2003), and protrusion is thought to result 
from F-actin polymerization against the membrane (Ponti, Machacek et al. 2004). 
In the cell, a densely-packed network of short, stiff, branched filaments exert the  
 3
  
 
Figure 2. Treadmilling/dendritic nucleation model for leading edge 
protrusion. (1) Receptors are activated by extracellular signals. (2) Active Rho-
family GTPases and PIP2 are produced by the associated signaling pathways, 
leading to (3) activation of WASp/Scar proteins. (4) Actin branches are formed 
when WASp/Scar proteins bring an actin monomer together with Arp2/3 complex 
on the side of a pre-existing filament. (5) The new branch’s barbed end grows 
rapidly and (6) pushes the membrane forward. (7) Growth is terminated by 
capping protein within one or two seconds. (8) Hydrolysis of bound ATP on each 
actin subunit (yellow subunits) followed by γ phosphate dissociation (red 
subunits) causes aging. (9) Phosphate dissociation, ADP-actin filament severing 
and dissociation of ADP-actin from filament ends is promoted by ADF/cofilin. (10) 
The exchange of ADP for ATP (white subunits) is facilitated by profilin, returning 
subunits to (11) the profilin-bound ATP-actin pool, ready to elongate barbed 
ends. (12) PAK and LIM kinase are activated by Rho-family GTPases, leading to 
the phosphorylation of ADF/cofilin. This slows filament turnover. Reprinted from 
(Pollard and Borisy 2003) with permission from Elsevier. 
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force necessary for protrusion of lamellipodia (Fig. 2) (Borisy and Svitkina 2000; 
Pollard and Borisy 2003; Faix and Rottner 2006).  
 Filament growth is limited by depletion of the free G-actin pool within the cell, 
as well as by barbed end-capping proteins (Ponti, Machacek et al. 2004). 
Polymerization of the barbed end (toward the cell edge) and depolymerization of 
the pointed end (away from the cell edge) lead to an overall treadmilling effect on 
the actin filament that is thought to be the driving force behind protrusion of the 
leading edge. Treadmilling allows a strict control of actin filament stability; while 
capping proteins at the barbed end prevent further polymerization, 
depolymerization occurs at the pointed end. This leads to a replenishment of the  
free G-actin pool that allows the monomers to be recycled and assembled into 
the barbed ends of uncapped filaments, and has been suggested to be an 
efficient way for the cell to manage its mechanical and energetic resources 
(Wang 1985).  
 In order to maintain a pool of monomers ready to polymerize rapidly, the cell 
must coordinate the actions of G-actin-binding proteins and proteins that cap 
filament barbed ends (Pollard and Borisy 2003).  More than sixty classes of actin-
binding proteins are currently known, but there are a few that are considered 
core actin binding proteins, that seem to exhibit the minimal requirements for the 
very simplest motility. Among these core actin-binding proteins are ADF/cofilin, 
capping protein, Arp2/3 complex, an activator of Arp2/3 complex, and profilin 
(Pollard and Borisy 2003). Additionally, actin polymerization is regulated by the 
bound adenine nucleotide state of the G-actin monomers as well as actin-binding 
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proteins.  Mg-ATP binds a cleft in monomeric G-actin and stabilizes it. In this 
state, the actin readily polymerizes. Hydrolysis of the bound ATP to ADP acts as 
a timer. As the actin ages within the filament, it becomes more likely to have 
hydrolyzed ATP and be bound to ADP, which induces disassembly of the 
branched actin and binding of ADP-G-actin to ADF/cofilin, promoting severance 
and depolymerization of the ADP-bound subunits from the filament pointed end. 
Bound ADP is exchanged for ATP on the actin monomers by a nucleotide 
exchange factor, profilin. This effectively returns the polymerization-competent 
subunits (bound to ATP and profilin) to pool, now available to be incorporated 
into another growing filament. p21 activated kinase (PAK), when activated by 
Rac, can inhibit severing by ADF/cofilin through LIM kinase, which inactivates 
ADF/cofilin (Pollard and Borisy 2003). 
 Initiation of a new filament barbed end is thought to occur predominantly 
through de novo nucleation. Other possible mechanisms include severing or 
uncapping the barbed ends of existing filaments (Condeelis 1993; Zigmond 1996; 
Pollard and Borisy 2003).  De novo nucleation is mediated by the Arp2/3 
complex, a stable complex of the actin related proteins Arp2 and Arp3, and five 
novel subunits. Arp2/3 achieves this nucleation by capping the pointed ends of 
actin subunits, then initiating assembly of actin monomers onto the barbed end. 
The most widely accepted model of actin assembly in the lamellipodium is the 
dendritic nucleation model (Pollard, Blanchoin et al. 2000). Activated by 
upstream signals, including those from the Rho GTPases, Rac and Cdc42, 
Wasp/Scar proteins bring the free actin subunit, Arp2/3 complex, and existing 
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actin filament together. Arp2/3 associates with the free actin and the actin 
incorporated into existing filaments, promoting the formation of branches on the 
sides of filaments, that jut out at a 70° angle (Amann and Pollard 2001; Pollard 
and Borisy 2003). Wasp/Scar proteins and actin filaments are co-activators of 
Arp2/3 complex, and cortactin binds and activates Arp2/3 while stabilizing actin 
branches (Pollard and Borisy 2003; Weaver, Young et al. 2003).  
 Filaments continue to lengthen until capped by capping protein. This serves 
two main purposes: it controls where the actin network exerts force on the 
plasma membrane to cause protrusion, and it controls filament length which is 
important because shorter filaments are stiffer than long ones, exerting pressure 
on the membrane more efficiently (Pollard and Borisy 2003). Crosslinking of actin 
filaments lends strength to the network, allowing a forward protrusion of the 
growing actin network toward the cell edge, rather than slipping backward toward 
the cell cortex. Filamin and the Arp2/3 complex are among the molecules thought 
to have crosslinking action (Pollard and Borisy 2003). 
 
Actin in the Filopodium 
 Unlike the branched actin network that drives the lamellipodium, filopodia 
(thin, rod-like surface protrusions of the membrane) are driven by parallel, linear, 
bundles of F-actin. Filopodial actin bundles lack the actin branch-nucleating 
system seen in lamellipodia, and are thought to be controlled by a different set of 
regulatory molecules (Faix and Rottner 2006; Steffen, Faix et al. 2006). However, 
in many systems, it appears that filopodia form from the lamellipodium, 
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suggesting it may be a precursor structure for filopodia. In this manner, select 
actin filaments are elongated and bundled, and it appears that uncapping of 
filaments in addition to elongation are key to dynamic actin modulation (Borisy 
and Svitkina 2000; Faix and Rottner 2006). Formins are dimerized scaffolding 
molecules that may play an important role in elongation and uncapping of 
filaments. They are actin nucleators that remain bound to the barbed end, 
moving along the filament as it elongates. By doing so, formins prevent capping 
of the filament, thereby promoting elongation of unbranched F-actin. Some 
formins may also depolymerize, sever, or bundle actin (Chhabra and Higgs 
2007). The actual mechanism of filopodial bundling is still unclear, but the 
structural and functional differences between filopodia and lamellipodia are easily 
seen. Filopodia are thought to serve a sensory role, and may be important in 
chemotactic, or directional migration (Steffen, Faix et al. 2006). 
 
Adhesion Dynamics 
 Adhesion to the ECM is mediated through focal adhesions, specialized 
regions of the plasma membrane. There are two main, broad categories of focal 
adhesions described so far: focal complexes that quickly form and turn over at 
the leading edge of a cell within lamellipodial protusions, and focal adhesions 
that are larger, more stable, and more highly organized at the rear and sides of 
the cell (Fig. 3) (Petit and Thiery 2000; Zaidel-Bar, Ballestrem et al. 2003). Some 
mature adhesions degrade slightly; referred to as fibrillar adhesions, these are 
thought to be important for ECM modification (Broussard, Webb et al. 2008). 
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Figure 3. Adhesion dynamics model. Nascent adhesions formed at the front 
either undergo turnover, which is predominantly controlled by kinase signaling, or 
mature in response to contractile forces. Mature adhesions can disassemble in a 
microtubule-dependent manner or be transformed into fibrillar adhesions. Trailing 
adhesions arise as a result of fusion of additional nascent adhesions and 
remaining fibrillar adhesions. Once formed, trailing adhesions slide because of 
tension from attached stress fibers and either eventually disassemble or detach 
in the form of membrane ‘footprints’. Reprinted from (Broussard, Webb et al. 
2008) with permission from Elsevier. 
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In this dissertation, I will refer generally to focal adhesions, though those in this 
study tended to form within 1-2 μm of the cell edge and turn over rapidly. The 
primary transmembrane components found in focal adhesions are integrins. 
These function in adhesion and signaling to the cytoskeletal matrix from multiple 
ECM components via a large multimolecular complex of structural proteins, such 
as α-actinin, vinculin, and filamin and regulatory proteins, such as gelsolin, 
tensin, and zyxin, that can affect actin nucleation, capping, and crosslinking (Petit 
and Thiery 2000). Although the mechanism by which adhesions assemble is 
poorly understood, it appears that adhesion molecules assemble sequentially, 
individually, or in small complexes, rather than as a large, pre-assembled 
complex recruited to the adhesion nucleation site (Webb, Parsons et al. 2002). 
 Initiation of adhesion assembly is thought to be triggered by aggregation of 
integrins at the plasma membrane, likely as a result of an extracellular stimulus 
(Fig. 4).  Upon formation, new focal complexes contain the regulatory molecule, 
talin, and focal adhesion kinase (FAK) —both responsible for adhesion 
disassembly. Ligand binding and/or integrin aggregation is required to recruit 
FAK, tensin, α-actinin, vinculin, and talin (Webb, Parsons et al. 2002). New 
adhesions contain the adapter molecules, vinculin and paxillin, that act to bind 
signaling molecules and actin cytoskeletal components at the plasma membrane. 
Studies using GFP-tagged proteins have shown that paxillin and α-actinin join the 
adhesion sequentially (Webb, Parsons et al. 2002). Paxillin contains multiple 
protein-protein binding sites, including proline-rich residues and a Src homology 
3 (SH3)-binding domain that is regulated by tyrosine phosphorylation 
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Figure 4. Focal adhesion. Focal adhesions are composed of more than 125 
structural and signaling proteins (only a few examples are shown here) that link 
the ECM to the actin cytoskeleton. Following extracellular stimulation of β-
integrin heterodimers, integrins become active, and molecules are recruited 
individually and in small pre-formed complexes to the forming adhesion site. 
Adapted from (Deakin and Turner 2008).  
 
 
 11
 (Petit and Thiery 2000). Interestingly, paxillin also contains multiple leucine-rich 
motifs, each of which have shown some selective protein binding, and interact 
with important adhesion-regulating molecules such as FAK, GIT1, vinculin, and 
the Rac GEF, PIX (Nayal, Webb et al. 2006). Binding of GIT1 to PIX, and then 
PIX to PAK, forms a multimolecular signaling complex. PIX is upstream of PAK, 
which is known to regulate adhesion disassembly (Turner, Brown et al. 1999). 
There is evidence suggesting paxillin, PAK, and PIX assimilate into the growing 
adhesion as a small, pre-formed complex (Webb, Parsons et al. 2002). Paxillin 
binds GIT1 in a phosphorylation-dependent manner, then targets it to the leading 
edge, where GIT1 is thought to regulate protrusion and promote adhesion 
disassembly. GIT1 targets the complex to the leading edge and adhesion sites in 
multiple cells types, including epithelial cells and fibroblasts (Nayal, Webb et al. 
2006). Once assembled, adhesions may stabilize protrusions and serve as 
traction for the cell as it propels its body in the direction of migration, but these 
adhesions must also disassemble for the cell to effectively continue the migration 
process.  
 Adhesions assemble sequentially, but disassembly is more than a simple 
reversal of the assembly process. For example, paxillin and α-actinin 
disassemble from adhesions simultaneously, whereas during assembly, they are 
recruited sequentially (Laukaitis, Webb et al. 2001; Webb, Parsons et al. 2002).  
In addition, it is clear that a number of adhesion components are essential for 
proper disassembly. Phosphorylation of paxillin is thought to be important in the 
formation of focal adhesions;  however, it has also been implicated in adhesion 
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disassembly, through recruitment of FAK (Zaidel-Bar, Milo et al. 2007). Studies 
have shown that FAK over-expression leads to enhanced mobility (Cary, Chang 
et al. 1996; Petit and Thiery 2000), and that FAK knockdown cells spread poorly, 
migrate more slowly, and have more focal adhesions than controls (llic, Furuta et 
al. 1995; Petit and Thiery 2000). These data indicate an essential role for FAK in 
adhesion disassembly, and is supported by a more recent study showing that 
FAK is indeed required for adhesion disassembly (Tilghman, Slack-Davis et al. 
2005). PAK is also an important regulator of adhesion disassembly, although its 
mechanism remains to be clarified. PAK’s downstream effectors, MLCK and LIM 
Kinase, are known regulators of the cytoskeleton, and are possible players in 
PAK-mediated adhesion disassembly (Webb, Parsons et al. 2002). The role of 
talin in adhesion disassembly is an interesting one; it mediates connectivity of 
integrins and the actin cytoskeleton. Proteolysis of talin by the calcium-
dependent protease, calpain, is a rate limiting step in adhesion disassembly, as 
seen in NIH 3T3 cells (Franco, Rodgers et al. 2004). Furthermore, disassembly 
of paxillin, vinculin, and zyxin from adhesions are dependent upon calpain-
mediated cleavage of talin at the adhesion site. Recent studies have indicated 
adhesion turnover is dependent on coordination of microtubules, the actin 
cytoskeleton, signaling and structural proteins, and integrins (Franco, Rodgers et 
al. 2004; Broussard, Webb et al. 2008). Despite the importance of adhesion 
assembly and disassembly for effective migration, adhesion turnover is poorly 
understood on a molecular level.  
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Rho Family GTPases 
Rho family GTPases represent a large portion of the Ras superfamily of 
small GTPases, with an average size of approximately 21 kD (Rossman, Der et 
al. 2005). Reorganization and polymerization of the actin cytoskeleton is 
modulated by members of the Rho family of small GTPases, of which there are 
approximately twenty currently known in mammals (Cain and Ridley 2009). The 
best studied of these twenty are Rho, Rac, and Cdc42. GTPases undergo 
conformational changes as they cycle between an inactive (GDP-bound) and an 
active (GTP-bound) state (Hall 1998; Bishop 2000; Ridley 2001; Etienne-
Manneville 2004). The cycling of these molecules between an active and inactive 
state is regulated by guanine nucleotide exchange factors (GEFs), which activate 
GTPases by facilitating the exchange of GDP for GTP, and GTPase-activating 
proteins (GAPs) that stimulate intrinsic GTPase activity, promoting GTP 
hydrolysis and thereby returning the GTPase to its inactive state. In the active 
conformational state, GTPases can interact with downstream targets, or effector 
molecules, to elicit a biological response. In effect, GTPases act as molecular 
switches in signaling cascades (Cerione and Zheng 1996; Aspenström 1999).  
Rho GTPases are well established as regulators of adhesion formation 
(Hall 1994; Turner, Brown et al. 1999; Petit and Thiery 2000) and other 
cytoskeletal modulation (Fig. 4). Rac stimulates extension of the initial 
lamellipodial protrusion and promotes the formation of associated adhesions 
(Ridley and Hall 1992; Hotchin and Hall 1995; Petit and Thiery 2000). Rho is 
associated with maturation of nascent adhesions as well as the formation of  
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Figure 5. Rac, Rho, and Cdc42 are key regulators of cell migration. Rac 
activation stimulates protrusion of the lamellipodium and the formation of nascent 
adhesions that stabilize the protrusion. Rho activity promotes stress fiber 
formation and generation of contractile forces that allow detachment and 
retraction of the rear of the migrating cell. Rho also promotes maturation of 
nascent adhesions. Cdc42 stimulates the formation of filopodial protrusions and 
promotes the establishment and maintenance of cell polarity, which is essential 
for directional migration.  
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stress fibers, which are thought to impede migration (Ridley and Hall 1992; 
Hotchin and Hall 1995; Chrzanowska-Wodnicka and Burridge 1996; Rottner, Hall 
et al. 1999; Petit and Thiery 2000). Cdc42 regulates filopodium formation and 
promotes the establishment and maintenance of cell polarization, which is 
essential for directional migration (Nobes and Hall 1995). While the role of these 
Rho Family GTPases in regulating cell migration and adhesion dynamics is well 
established, much less is known about the regulatory molecules that contribute to 
these processes and the mechanisms by which they function. 
 
Interactions and Crosstalk Between Rho GTPase Pathways 
 The Rho family GTPases must coordinate their activity in order to 
effectively control migratory behavior. Therefore, it is not surprising that much 
crosstalk occurs among Rac, Rho, and Cdc42 pathways. One pathway consists 
of Cdc42 activation at the leading edge of a cell promoting filopodial formation 
and Rac activation, leading to protrusion of the leading edge and finally 
stimulating Rho activation which promotes the necessary contractile forces for 
effective migration (Kozma, Ahmed et al. 1995; Nobes and Hall 1995; Burridge 
and Wennerberg 2004). In particular, the protrusive activity of Rac is frequently 
considered to act as an opposing force to the stabilizing stress fiber and focal 
adhesion formation and contractile forces generated in a Rho-dependent 
manner. It follows that Rac and Rho must coordinate their activation states so 
that they compliment one another, rather than hindering the other’s actions. This 
frequently occurs via crosstalk in the form of positive or negative regulation of 
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one GTPase by another. Although there are several examples of Rac acting 
upstream of Rho to activate it, interestingly, there are several cases showing that 
Rac can also function to inactivate Rho, or vice versa (Sander, ten Klooster et al. 
1999; Burridge and Wennerberg 2004).  In Swiss 3T3 cells, the Rac GEF Tiam1 
activates Rac, causing a decrease in Rho activation following stimulation with 
PDGF. However, it was noted that basal levels of Rho activation are necessary 
to maintain Rac-mediated morphology in these cells, which supports the idea that 
a positive feedback loop exists between Rho and Rac (Sander, ten Klooster et al. 
1999). Others have found, with the use of FRET biosensors, that Rac activation 
leads to a localized decrease in active Rho at the leading edge of migrating 
HEK293T cells in response to stimulation with PDGF (Pertz, Hodgson et al. 
2006). Clearly, cell shape and motility are controlled by a delicate balance 
between Rac and Rho activation. 
This crosstalk can be mediated in a number of ways. One GTPase may 
stimulate activation of another by activating a GEF. Conversely, one GTPase 
may inhibit activation of another by activating a GAP. One example of this GAP-
mediated crosstalk is Rac-mediated activation of p190 RhoGAP, which leads to 
Rho down-regulation (Nimnual, Taylor et al. 2003; Burridge and Wennerberg 
2004; Bustos, Forget et al. 2008). Interestingly, this can occur through multiple 
mechanisms. One group found the isoform p190B RhoGAP binds directly to 
active Rac in COS7 cells in order to decrease Rho activation and thereby 
regulate cell shape (Bustos, Forget et al. 2008). Another group has shown 
reactive oxygen species production can be stimulated by Rac activation, which 
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then inhibits low-molecular-weight protein tyrosine phosphatases, leading to an 
increase of p190 RhoGAP phosphorylation and activation. This ultimately leads 
to a decrease in Rho activation, and is required for the promotion of Rac-induced 
membrane ruffling and integrin-mediated cell spreading in HeLa cells (Nimnual, 
Taylor et al. 2003; Burridge and Wennerberg 2004). GTPases may also affect 
one another’s activity indirectly, through interaction of their downstream effectors, 
circumventing direct regulation of downstream GTPases. For example, when 
constitutively active, the Rac and Cdc42 effector, PAK, causes the dissolution of 
focal adhesions and stress fibers. It has been suggested that it does so by 
phosphorylating and thereby inhibiting MLCK, a downstream effector of Rho 
(Burridge and Wennerberg 2004).  Because there are multiple signaling 
pathways mediated by Rho GTPases, several different GEFs and GAPs, and a 
wide variety of downstream effectors, it is clear that crosstalk is an important and 
complex mechanism of signal coordination regulating the steps of cell migration. 
 
Regulation of Rho Family GTPases 
 The activation of Rho family GTPases is tightly controlled by guanine 
nucleotide exchange factors (GEFs).  Currently, there are approximately 80 
known GEFs (Cain and Ridley 2009). All Rho family GEFs contain a Dbl-
homology (DH) domain. This domain catalyzes the dissociation of GDP (Sjoblom, 
Jones et al. 2006), while stabilizing the nucleotide-free intermediary conformation 
(Kaibuchi, Kuroda et al. 1999), in which the released GDP is preferentially 
replaced by GTP because of a favorable intracellular ratio of GTP to GDP 
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(Schmidt and Hall 2002; Rossman, Der et al. 2005). GTPase specificity is 
thought to be determined by the interface between the GTPase and non-
conserved regions of the DH domain. Biochemical studies by several labs have 
verified the importance of these non-conserved regions, and often a single amino 
acid change terminates normal GTPase recognition and allows for recognition of 
another Rho GTPase not typically affected by the GEF (Manser, Loo et al. 1998; 
Karnoub AE 2001; Rossman, Der et al. 2005).  
 Adjacent, and C-terminal to the DH domain, is a pleckstrin homology (PH) 
domain.  The PH domain is known for lipid, phosphoinositide, and protein-
binding, and is thought to be responsible for membrane-targeting. However, it 
may also affect the activity of the DH domain, since both domains together are 
typically the minimum functional unit essential for GEF activity (Rameh, 
Arvidsson et al. 1997; Schmidt and Hall 2002; Jaffe, Hall et al. 2005) and both 
may play a role in GTPase binding. Cellular localization, interaction of 
phosphoinositides with the PH domain, tyrosine (Tyr) phosphorylation, 
oligomerization, and other protein-protein interactions via the PH domain 
frequently regulate Rho family GEFs (Aghazadeh, Lowry et al. 2000; Das, Shu et 
al. 2000; Bi, Debreceni et al. 2001; Russo, Gao et al. 2001; Kubiseski, Culotti et 
al. 2003; Schiller, Chakrabarti et al. 2006; Itoh, Kiyokawa et al. 2008). 
 In addition, some GEFs also have Src homology (SH2 and SH3) domains, 
which mediate protein-protein interactions and are commonly found in molecules 
involved in signal transduction. Approximately one-third of all known human Rho 
family GEFs contain at least one SH3 domain, and some studies indicate a 
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possible role for them in GEF activity regulation (Schiller, Chakrabarti et al. 2006; 
Hamann, Lubking et al. 2007; Kawasaki, Sagara et al. 2007; Mitin, Betts et al. 
2007). For example, the SH3 domain of the RhoA/Cdc42 GEF, Ost, appears to 
inhibit its cellular transforming activity (Lorenzi MV 1999; Schiller, Chakrabarti et 
al. 2006) by promoting normal Rho GTPase activation (Rossman, Der et al. 
2005). The SH3 domains of the Rac/Cdc42 GEFs, Asef1 and Asef2, are 
necessary for the auto-inhibition of these molecules (Hamann, Lubking et al. 
2007; Kawasaki, Sagara et al. 2007; Murayama, Shirouzu et al. 2007). 
Additionally, the Rho GEF, Trio, which contains two SH3 domains, requires the 
presence of its most N-terminal SH3 domain to exert an active effect on 
downstream effectors (Estrach, Schmidt et al. 2002; Schiller, Chakrabarti et al. 
2006). More commonly, the SH3 domain is required for docking with other 
proteins, such as scaffolds and effectors (Petit and Thiery 2000). 
 
Asef Family Guanine Nucleotide Exchange Factors 
 
Asef1 
 Asef (now Asef1) is a Rho Family GEF that activates Rac1 and Cdc42, 
originally identified in a two-hybrid screening of a human fetal brain library, using 
the armadillo binding repeat of APC as bait. Like all known Rho GEFs, it contains 
conserved DH and PH domains, and an SH3 domain which is found in some, but 
not all Rho GEFs. Interestingly, Asef1 activity appears to be stimulated by APC 
binding which has been shown to occur by APC-mediated relief of Asef1’s auto-
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inhibitory conformation in which the SH3 domain interacts with a C-terminal 
region of the molecule, thereby blocking the catalytic DH domain and 
simultaneously making interaction with other proteins via the SH3 domain 
energetically unfavorable (Kawasaki, Senda et al. 2000; Mitin, Betts et al. 2007). 
Asef1 contains two conserved Tyr residues, one of which (Tyr 104) is located 
within the APC-binding region (ABR). Asef1 appears to be translocated to the 
plasma membrane in a PH domain-dependent manner, then phosphorylated at 
Tyr 104 and activated in a Src-dependent manner (Itoh, Kiyokawa et al. 2008). 
Specificity of Asef1 for Cdc42 or Rac1 activation is thought to be cell-type 
specific, in at least some cases. In MDCK cells, APC and Asef1 co-localize in the 
cytoplasm and concentrate within lamellipodial ruffles at the leading edge, and 
Asef1 expression is associated with an increase in Rac-mediated morphology 
including increased protrusion and ruffling (Kawasaki, Senda et al. 2000). Others 
have found in mouse fibroblasts that Asef1 expression coincides with filopodial 
formation; morphology characteristic of Cdc42 activation. Moreover, they have 
rescued this Asef1-mediated phenotype by blocking Cdc42 with expression of 
the Cdc42/Rac Interacting Binding (CRIB) domain of Cdc42 effector, N-Wasp, 
which effectively acts as a Cdc42 dominant negative (Mitin, Betts et al. 2007). 
Because Asef1 activates Cdc42 and Rac1, and its expression increases the 
morphology associated with these important regulators of the actin cytoskeleton, 
Asef1 is thought to be an important regulator of cell migration. 
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Collybistin 
 Collybistin is an Asef family GEF highly expressed in brain and found in 
very low levels in heart and skeletal muscle with no evidence of expression in 
other tissues. It was first identified in a yeast two-hybrid screening for molecules 
that interacted with gephyrin, a scaffolding protein thought to organize 
postsynaptic inhibitory glycine receptor clusters and γ-aminobutyric acid type A 
receptors (GABAARs) and anchor these receptors to the cytoskeleton in neurons 
(Kins, Betz et al. 2000). Collybistin induces gephyrin clustering and has been 
shown to be necessary in hippocampal neurons for proper localization and 
maintenance of gephyrin and gephyrin-dependent GABAARs in the postsynaptic 
membrane (Papadopoulos, Eulenburg et al. 2008). Although collybistin is a Dbl 
family GEF, having the requisite DH and PH domains, it lacks the ABR found in 
the other Asef family GEFs (Kins, Betz et al. 2000; Mitin, Betts et al. 2007). 
Additionally, only some isoforms include an SH3 domain (Kins, Betz et al. 2000).  
Collybistin is a Cdc42-specific GEF, and its binding to gephyrin appears to act as 
a negative regulator of Cdc42 activation (Xiang, Kim et al. 2006; Papadopoulos, 
Eulenburg et al. 2008). This has led some researchers to speculate that 
collybistin plays an important role in the initial stages of synapse formation, but 
must be turned off when no longer required (Papadopoulos, Eulenburg et al. 
2008). Mutations in collybistin have been linked to epileptic pathology, further 
supporting a role for this GEF in synaptogenesis (Harvey, Duguid et al. 2004). 
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Asef2 
 The Rho Family GEF, Asef2, was identified in a database search for 
molecules with homology to Asef1. Because it has only recently been described, 
very little is known about Asef2. Most studies to date have focused on the 
biochemical nature and structure of the molecule. Like Asef1, it activates Cdc42 
and Rac1, and comprises a DH, PH, and SH3 domain, with an ABR adjacent and 
N-terminal to the SH3 domain (Hamann, Lubking et al. 2007; Kawasaki, Sagara 
et al. 2007). The ABR in Asef2 shares 50% homology with that of Asef1. 
Interestingly, yeast two-hybrid assays determined that the Asef2 ABR alone (or 
SH3 domain alone) is not enough to bind APC, but rather,  the SH3 domain is 
also required for effective APC binding (Kawasaki, Sagara et al. 2007). APC 
binding stimulates Asef2 activity, and deletion of the N-terminus of the molecule 
including the ABR and SH3 domain activates Asef2 without need of APC 
stimulation, apparently relieving auto-inhibition caused by an intra-molecular 
interaction between a C-Terminal region of Asef2 and the SH3 domain, with the 
ABR acting to stabilize this interaction. Similar to the Rho Family GEF, Vav, 
Asef2 depends on it’s C-Terminal tail for proper function—deletion of this region 
does not render Asef2 constitutively active like deletion of the N-Terminus 
(including the ABR and SH3 domain) does, instead it prevents proper binding of 
Cdc42 (Hamann, Lubking et al. 2007). Surprisingly, Asef2 lacks the Tyr 
phosphorylation required for activity of Asef1, and therefore Asef2 activity 
appears to be Src-independent (Itoh, Kiyokawa et al. 2008).  
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 Asef2 seems to activate Cdc42 and Rac1 specifically in a cell-type specific 
manner in many cases. Expression of activated Asef2 in MDCK cells increased 
Rac1-type morphology including increased lamellipodial ruffles. In contrast, 
activated Asef2 in HeLa cells increased filopodia but not ruffling, associated with 
Cdc42 activation. In trans-well assays used to assess cell motility, MDCK cells 
expressing full-length Asef2 showed increased motility, and cells expressing 
constitutively active Asef2 had further enhanced motility, quantified by the 
number of cells able to migrate through pores in a membrane separating two 
wells. Further, in SW480 colorectal cancer cells expressing a truncated APC 
associated with pathology and, specifically, with increased Asef1-mediated 
motility, shRNA targeting Asef2 lead to decreased migration in a trans-well. This 
implies full-length Asef2 and mutant APC are important for promotion of SW480 
cell migration, and suggests a role for Asef2 in colorectal cancer pathology 
(Kawasaki, Sagara et al. 2007).   
Little is known about Asef2’s downstream effector and other associated 
molecules and the molecular mechanism by which it regulates cell migration. 
Interestingly, Asef2 and APC associate with the scaffolding protein, Neurabin2. In 
HeLa cells, Neurabin2 and Asef2 co-localize and translocate from the cytoplasm 
to the cell periphery when stimulated by HGF. Knockdown of Neurabin2 
significantly reduces the ability of HeLa cells to migrate in a trans-well assay after 
HGF stimulation and decreases the number of filopodia, though Neurabin2 has 
no impact on Asef2-mediated Cdc42 or Rac1 activation (Sagara, Kawasaki et al. 
2009). This indicates that Neurabin2 associates with Asef2, but does not act to 
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regulate migration and actin modulation directly through Asef2 activation. Much is 
left to discover about the molecules with which Asef2 interacts, both directly and 
indirectly, and how these molecules cooperate to regulate cell migration. 
 
Role of PI3K and its Phosphoinositide Products in Cell Migration 
 PI3Ks act by phosphorylating phosphoinositides at the 3’ position that go 
on to bind and regulate downstream effectors, thereby acting as second 
messengers. There are three classes of PI3K family lipid kinases which are 
characterized by their sequence homology and substrate specificity. Class I 
PI3Ks are the most closely studied group, and can be activated by tyrosine 
phosphorylation, G-protein coupled receptor (GPCR) signaling and Ras 
signaling. Class I PI3Ks and their lipid products, PtdIns(3,4)P2 and 
PtdIns(3,4,5)P3, have been shown to regulate cell polarity and migration 
(Carpenter and Cantley 1996; Cain and Ridley 2009). Class I PI3Ks are 
frequently studied with the use of the chemical inhibitors, wortmannin and 
LY294002. Class II PI3Ks have also been implicated in cell adhesion and 
migration, but are poorly understood at this time due to a lack of specific 
chemical inhibitors. Only one Class III PI3K has been identified in mammals, but 
has not been shown to play any role in migration (Carpenter and Cantley 1996).   
 A complex relationship exists between the Rho GTPases and PI3K and its 
products. Rac and Cdc42 have been shown to bind and activate PI3K. 
Interestingly, Rac activity stimulates PtdIns(3,4)P2 and PtdIns(3,4,5)P3 synthesis 
(Tolias, Cantley et al. 1995) and actin uncapping in vitro and in vivo (Cain and 
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Ridley 2009). Additionally, active Rac, PtdIns(3,4)P2, and PtdIns(3,4,5)P3 are 
concentrated at the leading edge and in ruffles of migrating cells (Tolias, Cantley 
et al. 1995; Kraynov, Chamberlain et al. 2000). PtdIns(3,4)P2 and PtdIns(3,4,5)P3 
binding regulates activity of many Rho Family GEFs and GAPs, such as pRex1 
and ArhGAP15, implying a possible positive feedback loop between Rho 
GTPases, such as Rac, and PtdIns(3,4)P2 and PtdIns(3,4,5)P3 synthesis, which 
could lead to a rapid response to extracellular stimuli, such as chemokines 
(Kraynov, Chamberlain et al. 2000; Cain and Ridley 2009). While Rho has been 
implicated in PtdIns(3,4)P2 synthesis in fibroblasts, and Arp2/3-driven actin 
polymerization can be stimulated by phosphoinositide activity occurring 
downstream of Rac, Rac and Rho can also be activated downstream of 
phosphoinositide signaling (Kraynov, Chamberlain et al. 2000; Cain and Ridley 
2009).  
Phosphoinositides are key regulators of actin-modulating proteins, and as 
such, play an important role in regulating cell migration, adhesion, polarity and 
chemotaxis (Fenteany 2003; Cain and Ridley 2009).  PI3K-mediated production 
of PtdIns(3,4,5)P3 is sufficient to recruit WAVE2 to the plasma membrane, where 
it binds to and is subsequently activated by PtdIns(3,4,5)P3. This activation of 
WAVE2 occurs downstream of Rac activation, and leads to rapid Arp2/3-
mediated polymerization of the actin cytoskeleton, promoting protrusion of the 
lamellipodium (Oikawa, Yamaguchi et al. 2004). The ERM protein, ezrin, binds 
PI3K and regulates its cellular activity that leads to Akt activation (Yin and 
Janmey 2003).  In addition, the lipid product of PI3K is thought to directly bind 
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and activate Akt through its PH domain following PI3K-stimulation by platelet 
derived growth factor (PDGF) (Carpenter and Cantley 1996).  
 
Role of Akt in Cell Migration 
 Akt, also known as Protein Kinase B (PKB), was originally identified as a 
homologue to the transforming oncogene, v-Akt. It is a serine/threonine kinase 
and a downstream effector of PI3K that is recruited to the plasma membrane via 
interaction of its PH domain with the PI3K lipid products, PtdIns(3,4)P2 and 
PtdIns(3,4,5)P3, which, along with other molecules such as 3-phosphoinositide 
kinase 1 (PKD1), activate Akt (Kim, Kim et al. 2001).  The Akt/PKB family of 
kinases includes three structurally homologous isoforms, Akt1, -2, and -3. 
Isoforms -1 and -2 are expressed ubiquitously, whereas Akt3 expression is 
limited, and is the predominant isoform found in the brain (Irie, Pearline et al. 
2005). Once activated, Akt may affect a number of different responses in cells, 
and has been implicated in regulation of cell survival and glucose metabolism, as 
well as promoting chemotaxis (Kim, Kim et al. 2001). When Akt signaling is 
enhanced or deregulated, as it frequently is in many human cancers (Bellacosa, 
Kumar et al. 2005), it can play an important role in promoting cancer cell invasion 
and metastasis (Irie, Pearline et al. 2005).  
Akt can promote invasion and metastasis by promoting an epithelial–
mesenchymal transition (EMT) and by stimulating the secretion of 
metalloproteinases (Kim, Kim et al. 2001; Bellacosa, Kumar et al. 2005). The 
EMT is an important part of normal embryological development. It essentially 
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consists of a series of morphological changes that occur in epithelial-like cells 
that have three membrane domains: apical, lateral, and basal; have tight 
junctions between apical and lateral domains; are cohesive, forming cell layers; 
have a polarized arrangement of organelles and cytoskeletal components, 
oriented apicobasally; and they lack individual motility within their local 
environment. During this transition, epithelial cells become more like 
mesenchyme. They loosen their cell-cell contacts and no longer form continuous 
sheets of cells. They lose their apicobasal membrane distribution, and their 
organelles and cytoskeletal components are no longer oriented in this manner. 
Importantly, after undergoing EMT, cells become motile and possess invasive 
properties (Larue and Bellacosa 2005). It is not surprising that tumor cells might 
undergo a similar process allowing them to separate from a tumor mass during 
metastasis.  
Another important role Akt plays in invasion and metastasis is promotion 
of metalloproteinase secretion. In particular, the matrix metalloproteinases 
(MMPs) are important enzymes that degrade the ECM in a zinc-dependent 
manner, and are thought to play a critical role in tumor invasion. In order for a 
tumor cell to invade the surrounding tissue, it must be able to break through 
biological barriers such as basement membranes, in addition to expressing 
changes in adhesion and motility. This is facilitated by matrix degradation 
mediated by MMPs. MMP-9 expression appears to be regulated by Akt via 
activation of the transcription factor, nuclear factor κB (NF-κB) (Kim, Kim et al. 
2001). This suggests Akt promotes invasion through an MMP-9-mediated 
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mechanism. Thus, Akt appears to promote invasion and metastasis by enabling 
cells to dissociate from confluent, tightly-knit layers, and transform into a less 
rigidly organized morphology that is motile and can increase secretion of MMPs 
that aid the cell in breaking and maneuvering through biological barriers.   
In migrating HT-1080 human fibrosarcoma cells, a highly metastatic, 
invasive cancer cell line, GFP-Akt localizes to the leading edge membrane of 
migrating cells. Using a GFP-tagged PH domain of Akt as an indicator of PI3K 
activity, one research group also showed similar localization of active PI3K in 
migrating cells, and Akt localization was abrogated by the use of PI3K chemical 
inhibitors, suggesting PI3K acts locally on Akt to promote protrusion and 
migration. With the use of dominant negative, kinase dead, and lipid-binding 
defective mutants, it was determined that while Akt expression increases the rate 
of migration in a trans-well assay, Akt-mediated promotion of migration is 
dependent upon both Akt’s kinase activity and proper membrane translocation. 
Possible downstream effectors of Akt that would link it to actin cytoskeleton 
rearrangement are filamin and PAK. Filamin binds to Akt in vivo, localizes to the 
leading edge of migrating cells, and is essential for migration. Akt is also capable 
of stimulating PAK independently of Rac activation (Kim, Kim et al. 2001).     
  
Summary and Hypothesis 
 Cell migration is a complex process that can be broken down into four 
mechanical steps: protrusion of the leading edge, stabilization of the protrusion 
with cell-matrix adhesions, translocation of the cell body in the direction of the 
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protrusion, and finally, a contraction of the cell rear that leads to a release of the 
extracellular matrix. Migration is thought to be driven primarily by actin dynamics. 
The actin cytoskeleton is tightly regulated by the Rho family of small GTPases, 
including Rac, Rho, and Cdc42, that act as molecular switches regulated by their 
guanine nucleotide-bound state. GTPases are activated by GEFs, and 
inactivated by GAPs. In the active state they can interact with downstream 
effectors to elicit a biological response. The Rho GTPases are fairly well 
described in the literature, however very little is known about the individual GEFs 
that regulate their activity or the molecular mechanisms by which they function. 
Here, we investigate the role of a recently-described Rho family GEF, Asef2 and 
its molecular mechanism in regulating cell migration and its underlying 
processes. Asef2 is a member of the Asef family of GEFs, which typically 
activate Rac and/or Cdc42, and have been implicated in promoting migration and 
the protrusion of actin cytoskeletal structures. We hypothesize Asef2 acts 
through Rac, Rho, and/or Cdc42 to promote cell migration and adhesion turnover 
in a mechanism that may be dependent on other regulators of migration, such as 
kinases including PI3K and Akt/PKB. This enhanced Asef2-mediated migration 
may underlie a mechanism of cancer metastasis, which is linked to poor 
prognosis.  
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 CHAPTER II 
 
MATERIALS AND METHODS 
 
Generation of stable cell lines via retroviral transduction 
 Cell lines that stably express GFP (for use as control) or GFP-Asef2 were 
generated using a retroviral transduction system developed in the Nolan lab at 
Stanford University (Fig. 6). GFP-Asef2 was inserted into the LZRSneo retroviral 
vector following PCR-mediated cloning from a C1 vector containing GFP-Asef2 
that attached EcoRI and BamHI restriction sites to the construct. GFP was 
inserted into the LZRSneo vector similarly. Once GFP-Asef2-LZRSneo and GFP-
LZRSneo were generated, purified, and the DNA sequences verified, a calcium 
chloride delivery system was used to transfect Phoenix 293 packaging cells. 
Briefly, Phoenix cells were plated at approximately 80% confluency in a T75 
culture flask and incubated at 37°C overnight. 5-10 min prior to transfection, 4 μl 
chloroquine (25 mM) was added to the media on the Phoenix cells. A cocktail 
containing 62 μl calcium chloride, 8 μl (1 mg/ml) DNA, and 430 μl ddH2O was 
added gently to the cells, followed by 500 μl HBS (pH 7.0).   Cells were incubated 
at 37°C for 7-9 h, and the media refreshed.  Phoenix cells were drug selected 
with 5 μg/ml puromycin for one week. In order to harvest virus from the Phoenix 
cells, they were plated at medium density in a T75 flask for 24 h (one flask GFP, 
one flask GFP-Asef2), where they were cultured in 12 ml DMEM supplemented 
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with 10% heat-inactivated FBS and 1% penicillin/streptomycin. Meanwhile, 
300,000 HT-1080 target cells were plated in each of two T75 flasks where they 
were cultured in 12 ml DMEM supplemented with 10% heat-inactivated FBS and 
1% penicillin/streptomycin.  All cells were incubated overnight at 37°C. Virus was 
harvested by removing the supernatant from the Phoenix cells and filtering it with 
a 0.45μm-pore syringe-end filter, collecting the filtered supernatant in a vial. To 
each vial of filtered virus supernatant, polybrene was added for a final 
concentration of 4 μg/ml and gently mixed. Media from the target cells was 
aspirated and replaced with the virus/polybrene mixture. The target cells were 
incubated at 37°C for 9 h, then the media was aspirated and refreshed with 
DMEM supplemented with 10% FBS and 1% penicillin/streptomycin and the cells 
are incubated at 37°C overnight. Cells were drug selected with 400 μg/ml G418 
for 10 days. The resulting stably-expressing GFP and GFP-Asef2 HT-1080 cells 
were sorted by FACS to yield homogenous populations based on expression 
level, as determined by fluorescence intensity. GFP and GFP-Asef2 cell 
populations that fluoresced with comparable intensity were chosen for 
experimentation. 
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Figure 6. HT-1080 cells stably-expressing GFP or GFP-Asef2 were 
generated by a retroviral transduction system. Stable cell lines expressing 
GFP or GFP-Asef2 were generated as follows: GFP or GFP-Asef2 was cloned 
from the C1 vector by PCR, then the PCR product was inserted into the LZRSneo 
retroviral vector. Phoenix 293 packaging cells were transfected with the LZRS 
vector containing the construct, then drug selected with puromycin, and virus was 
harvested from the transfected packaging cells. Harvested virus was applied to 
the HT-1080 target cells and stably-expressing GFP or GFP-Asef2 cells were 
selected with G418. Populations were sorted according to expression level by 
FACS. 
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Trans-well Migration Assay 
 For trans-well migration assays, MCF-7 human carcinoma cells were 
transiently transfected with either GFP (control) or GFP-Asef2 with 
LipofectamineTM 2000 according to the manufacturer’s instructions. 50,000 
transfected MCF-7 cells were added to a 24-well trans-well plate (includes 12 
inserts) with 80 μm pores previously coated with Fn. The cells were incubated in 
the trans-well plate in serum-free DMEM at 37°C for 3 h. The remaining cells 
were swabbed from the inside of the insert and the membrane was fixed in 
methanol for 15 min at room temperature. Membranes were then stained with 
0.1% crystal violet for 15 min before washing three times in PBS. Crystal violet 
stain was eluted from the membranes with 10% acetic acid and the number of 
cells that passed through the pores of the insert was determined by measuring 
absorbance at 600 nm with a spectrophotometer. 
 
Scratch-wound Migration Assay 
For scratch-wound assays, 5 x 105 GFP-expressing or GFP-Asef2-
expressing HT-1080 cells were plated on 35 mm dishes previously coated with 
10 μg/ml Fn in PBS for 1 h at 37°C. The cells were allowed to adhere to the 
substrate while incubated overnight at 37°C in DMEM supplemented with 10% 
FBS and 1% penicillin/streptomycin. The resulting monolayer was then scratched 
with a 1 ml pipette tip, and refreshed with CCM1 with 2% FBS immediately prior 
to imaging. Cell migration data were generated from time-lapse images collected 
at 5 min intervals for 12 h, and used to calculate the wound-edge velocity, which 
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was determined by dividing the mean net displacement of the wound edge by the 
time interval. 
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Abstract 
 
 Asef2 is a recently identified Rho family guanine nucleotide exchange factor 
(GEF) that has been implicated in the modulation of actin, but its function in cell 
migration and adhesion dynamics is not well understood.  In this study, we show 
that Asef2 is an important regulator of cell migration and adhesion assembly and 
disassembly (turnover).  Asef2 localizes with actin at the leading edge of cells.  
Knockdown of endogenous Asef2 impairs migration and significantly slows the 
turnover of adhesions.  Asef2 enhances both Rac1 and Cdc42 activity in HT-
1080 cells, but only Rac1 is critical for the Asef2-promoted increase in migration 
and adhesion turnover. Phosphoinositide 3-kinase (PI3K) and the 
serine/threonine kinase Akt are also essential for the Asef2-mediated effects on 
migration and adhesion turnover.  Consistent with this, Asef2 increases the 
amount of active Akt at the leading edge of cells.  Asef2 signaling leads to an 
overall decrease in Rho activity, which is critical for stimulating migration and 
adhesion dynamics.  Thus, our results reveal an important new role for Asef2 in 
promoting cell migration and rapid adhesion turnover by coordinately regulating 
the activities of Rho family GTPases. 
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Introduction 
 Cell migration is a highly coordinated, tightly regulated process that begins 
with the extension of a protrusion, which is most likely driven by the 
polymerization of the actin cytoskeleton at the leading edge of cells (Wang 1985; 
Carson, Weber et al. 1986; Lauffenburger and Horwitz 1996; Borisy and Svitkina 
2000).  The formation of cell-matrix adhesions, which consist of transmembrane 
integrins along with cytoplasmic signaling and structural proteins, such as paxillin 
and vinculin, stabilize the protrusion and provide traction for translocation of the 
cell body forward (Turner, Glenney et al. 1990; Miyamoto, Teramoto et al. 1995; 
Beningo, Dembo et al. 2001; Zaidel-Bar, Ballestrem et al. 2003).  The constant 
assembly and disassembly of nascent adhesions, which is termed adhesion 
turnover, within leading edge protrusions is essential for continuous migration to 
occur (Webb, Donais et al. 2004), but is poorly understood on a molecular level.  
Emerging data indicate that the actin cytoskeleton plays a critical role in the 
formation, dynamics, and turnover of leading edge adhesions (Alexandrova, 
Arnold et al. 2008; Choi, Vicente-Manzanares et al. 2008; Lim, Lim et al. 2008), 
which underscores the importance of actin regulation in cell migration and its 
underlying processes.   
   Polymerization and reorganization of actin are modulated by members of 
the Rho family of small GTPases, which includes Rho, Rac, and Cdc42.  Rho 
GTPases, like many small GTPases, function as molecular switches and cycle 
between an inactive GDP-bound form and an active GTP-bound state (Hall 1998; 
Ridley 2001).  The cycling of these molecules is tightly controlled by GEFs, which 
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serve to activate the GTPases by promoting the exchange of GDP for GTP, and 
GTPase-activating proteins (GAPs) that increase their intrinsic GTPase activity 
and return them to an inactive state.  Once activated, the GTPases can convert 
upstream molecular signals into coordinated rearrangements of the actin 
cytoskeleton by modulating the activity of downstream effectors, which can 
ultimately contribute to the regulation of cell migration and adhesion dynamics 
(Ridley 2001).   
 Rac can promote migration by stimulating the initial extension of the 
leading edge protrusion and by subsequently inducing the formation of nascent 
adhesions within this region (Ridley and Hall 1992; Nobes and Hall 1995; 
Rottner, Hall et al. 1999).  Rho activity is associated with the maturation of 
nascent adhesions into larger, more mature focal adhesions and with the 
formation of stress fibers, which are thought to impede cell migration (Ridley and 
Hall 1992; Chrzanowska-Wodnicka and Burridge 1996; Rottner, Hall et al. 1999).  
Cdc42 can regulate the formation of filopodia as well as promote the 
establishment and maintenance of cell polarity, which is essential for directed 
migration (Nobes and Hall 1995; Etienne-Manneville and Hall 2003).  While the 
role of these GTPases in regulating migration and adhesion dynamics is well 
established, much less is known about the specific GEFs that contribute to these 
processes and the mechanisms by which they function. 
 Asef2 is a recently identified Rho family GEF that is composed of a N-
terminal APC binding region (ABR), which interacts with the tumor suppressor 
adenomatous polyposis coli (APC), an adjacent Src homology 3 (SH3) domain, a 
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central Dbl homology (DH) domain, and a Pleckstrin homology (PH) domain 
(Kawasaki, Sagara et al. 2007).  The binding of APC dramatically enhances the 
GEF activity of Asef2 by relieving it from an autoinhibitory conformation in which 
the ABR/SH3 domains are associated with the C-terminus of the molecule 
(Hamann, Lubking et al. 2007).  Following activation, Asef2 significantly 
increases the level of active Rac1 and Cdc42 in epithelial cells, indicating it has 
GEF activity toward these GTPases (Kawasaki, Sagara et al. 2007).  Asef2 is 
thought to regulate actin dynamics possibly through its interaction with the F-
actin binding protein Neurabin2 (Sagara, Kawasaki et al. 2009).  It is also 
implicated in the modulation of cell migration (Sagara, Kawasaki et al. 2009), but 
the molecular mechanisms by which it contributes to this process are currently 
unknown.   
 In this study, we show Asef2 promotes cell migration and the rapid 
turnover of adhesions.  It increases both Rac1 and Cdc42 activity, but only Rac is 
essential for the Asef2-mediated effects on migration and adhesion turnover.  
Asef2 regulates migration and adhesion dynamics through a mechanism that is 
dependent on PI3K and Akt.  Asef2 also decreases the amount of active Rho, 
which is critical for Asef2-promoted migration.  Thus, our results reveal an 
important function for Asef2 in regulating migration and adhesion turnover via a 
previously unknown mechanism, involving Rac, PI3K, Akt, and Rho.  
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Materials and Methods 
 
Antibodies and reagents 
 A rabbit polyclonal antibody against Asef2 was generated by 21st Century 
Biochemicals (Marlboro, MA) using the N- and C-terminal peptides 
MTSASPEDQNAPVGC and AEPKRKSSLFWHTFNRLTPFRK, respectively, as 
antigen.  Myc 9E10 polyclonal antibody, Cdc42-specific monoclonal antibody 
(clone B8), Rac1 C-14 polyclonal antibody, and phospho-Akt (Thr308) polyclonal 
antibody were obtained from Santa Cruz Biotechnology (Santa Cruz, CA).  Alexa 
Fluor® 488 and 555 anti-rabbit, Alexa Fluor® 488 and 555 anti-mouse, Alexa 
Fluor® 680 anti-mouse, and Alexa Fluor® 647-phalloidin were purchased from 
Molecular Probes (Eugene, OR). IRDye® 800 anti-mouse and 800 anti-rabbit 
were from Rockland Immunochemicals (Gilbertsville, PA).  Wortmannin was 
purchased from VWR.  Fibronectin, β-actin (clone AC-15) monoclonal antibody, 
FLAG M2 monoclonal antibody, α-tubulin antibody, vinculin (clone VIN-11-5) 
monoclonal antibody, and TRITC-phalloidin were from Sigma.  Paxillin 
monoclonal antibody was obtained from BD Bioscience Pharmingen (San Diego, 
CA).  Y-27632 and calyculin A were purchased from CALBIOCHEM®.  
LY294002 was from Cell Signaling (Beverly, MA).  Glutathione Sepharose beads 
came from Amersham.  CCM1 was purchased from Hyclone.  Secramine A was 
generously provided by the laboratories of Tomas Kirchhausen (Harvard Medical 
School, Cambridge, MA) and Gerald Hammond (University of Louisville, 
Louisville, KY).  It was synthesized by Bo Xu and G.B. Hammond. 
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 Plasmids 
 The full length Asef2 cDNA was generated by reverse transcription of 
HEK-293 cell RNA followed by amplification using the SuperScript™ One-Step 
RT-PCR kit (Invitrogen) with the primers: 5’-
ATGACTTCTGCCAGCCCTGAAGACC-3’ (forward) and 5’-
TTTCCGGAAGGGGGTGAGCCTGTTG-3’ (reverse).  The Asef2 cDNA was then 
sequenced and cloned into pEGFP-C3 vector (CLONTECH Laboratories).  Small 
interfering RNA (siRNA) constructs were prepared for Asef2, Rac1, Cdc42 and 
Akt by ligating 64-mer oligonucleotides into pSUPER vector as previously 
described (Zhang and Macara 2008).  The siRNA oligos contained the following 
19-nucleotide target sequences: Asef2 #1, 5’-TTGCGCAGCTAGCCACTAT-3’; 
Asef2 #2, 5’-TTCGTCAGATTGCGAGTGA-3’; and Cdc42 #2, 5’-
AAAGTGGGTGCCTGAGATA-3’.  Both Rac1 and Akt target sequences and 
Cdc42 target sequence #1 have been previously described (Katome, Obata et al. 
2003; Chan, Coniglio et al. 2005; Degtyarev, De Maziere et al. 2008; Wegner, 
Nebhan et al. 2008).  DN-Akt (Akt T308A/S473A) and KD-Akt (Akt 
K179A/T308A/S473A) were kindly provided by Brian Hemmings (Friedrich 
Miescher Institute, Basel, Switzerland) and Jeffrey Field (University of 
Pennsylvania, Philadelphia, PA).  mCherry-paxillin was a generous gift from 
Steve Hanks (Vanderbilt University, Nashville, TN).  Flag-tagged Asef2Δ204 was 
generously provided by Daniel Billadeau (Mayo Clinic, Rochester, MN).  Wild-
type Rac1 and Cdc42, CA-Rho (RhoA V14), and GST-tagged PAK binding 
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domain were kindly provided by Alan Hall (Memorial Sloan-Kettering Cancer 
Center, NY).  Myc-tagged wild-type RhoA and GST-tagged rhotekin binding 
domain were a generous gift from Sarita Sastry (University of Texas Medical 
Branch, Galveston, Texas). 
 
Cell culture and transfection 
 HEK-293 and HT-1080 cells were cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM) (Invitrogen) supplemented with 10% fetal bovine serum (FBS) 
(Hyclone) and penicillin/streptomycin (Invitrogen).  Phoenix 293 packing cells 
(from Gary Nolan, Stanford University) were cultured in DMEM with 10% heat-
inactivated FBS and penicillin/streptomycin and selected as previously described 
(Bryce, Clark et al. 2005).  Stable HT-1080 cells expressing GFP or GFP-Asef2 
were prepared by retroviral transduction as previously described (Bryce, Clark et 
al. 2005) and selected for stable expression by incubation with 400 μg/ml G418 
(Fisher) for 10 days.  Cells were sorted into populations based on expression 
level by fluorescence activated cell sorting (FACS).  HT-1080 cells were 
transiently transfected with Lipofectamine 2000 (Invitrogen) according to 
instructions from the manufacturer.   
 
Microscopy and image analysis 
 Images were collected using an inverted Olympus IX71 microscope 
(Melville, NY) with a Retiga EXi CCD camera (QImaging, Surrey, BC) and a 10X 
objective (NA 0.3) or a PlanApo 60X OTIRFM objective (NA 1.45).  Image 
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acquisition was controlled using MetaMorph software (Molecular Devices, 
Sunnyvale, CA), which was interfaced to a Lambda 10-2 automated controller 
(Sutter Instruments, Novato, CA).  An Endow GFP Bandpass filter cube 
(excitation HQ470/40, emission HQ525/50, Q495LP dichroic mirror) (Chroma, 
Brattleboro, VT) was used for EGFP and Alexa Fluor® 488.  For mCherry and 
Alexa Fluor® 555, a TRITC/Cy3 cube (excitation HQ545/30, emission HQ610/75, 
Q570LP dichroic mirror) was used.  For three color imaging, a far red filter cube 
(excitation HQ620/60, emission HQ700/75, Q660LP dichroic mirror) was used.  
Red fluorescent TIRF images were obtained by exciting with the 543 nm laser 
line of a HeNe laser (Prairie Technologies, Inc., Middleton, WI).  
  To quantify the enrichment of GFP-Asef2 and phospho-Akt Thr308, and 
total Akt at the leading edge of HT-1080 cells, images were collected and 
analyzed with Metamorph software. The integrated fluorescence intensity was 
determined for a region of interest at the cell edge and the background 
fluorescence intensity was subtracted from these values.  The fluorescence 
intensity was then normalized to the unit area.   
 
Immunocytochemistry 
 Cells were plated on coverslips for 1 h at 37°C and fixed with 4% 
paraformaldehyde/4% glucose in phosphate buffered saline (PBS) for 5 min.  
Prior to cell plating, the coverslips were pre-incubated with 10 μg/ml fibronectin 
(Fn).  Following fixation, cells were then permeabilized with 0.2% (v/v) Triton X-
100 for 5 min at room temperature.  Following each step, cells were washed 
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three times with PBS.  Cells were then blocked with 20% goat serum in PBS for 1 
h and incubated with primary antibody for 1 h followed by fluorescently-
conjugated secondary antibody for 1 h.  Antibodies were diluted in PBS with 5% 
goat serum.  After each step, cells were washed three times with PBS. 
Coverslips were mounted with Aqua Poly/Mount (Poly-sciences, Inc., Warrington, 
PA).  For total and phospho-Akt staining, cells were treated with a phosphatase 
inhibitor cocktail containing 1 mM peroxovanadate (Fisher) and 10 nM calyculin A 
for 15 min at 37°C in the dark prior to fixation. 
 
Migration Assay 
 For random migration assays, cells were plated at low density on culture 
dishes, pre-incubated with 10 μg/ml Fn, and allowed to adhere for 1 h at 37°C.  
Cells were then imaged in phase with a 10X objective every 5 min for 12 h.  
During microscopy, cells were maintained at 37oC in CCM1 with 2% FBS at pH 
7.4.  Cell migration data were generated from time-lapse images and used to 
calculate the migration velocity, which was determined by dividing the mean net 
displacement of the cell centroid by the time interval.  Wind-Rose plots were 
generated by plotting the XY-coordinates of 4-5 individual cells and transposing 
cell tracks to a common origin.  
 
Adhesion Turnover Assay 
 Wild-type and stably expressing GFP or GFP-Asef2 HT-1080 cells were 
transfected with 0.5 μg mCherry-paxillin cDNA and incubated at 37°C for 24 h.  In 
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some experiments, cells were co-transfected with 0.5 μg mCherry-paxillin cDNA 
and 2.5 μg Asef2 siRNA #1, Rac1 siRNA #1, Akt siRNA #1, pSUPER vector, 
scrambled siRNA, or KD-Akt cDNA.  Transfected cells were then seeded at low 
density on glass-bottom 35 mm Fn-coated microscopy dishes and incubated at 
37°C for 1 h.  Fluorescent time-lapse images were obtained at 15-30 sec 
intervals and the t1/2s for adhesion assembly and disassembly were determined 
as previously described (Webb, Donais et al. 2004) using Metamorph software. 
 
Rho family GTPase activity assays 
 HT-1080 stable cell lines were transfected with 3 μg of myc-RhoA, FLAG-
Cdc42, or FLAG-Rac1 cDNA and incubated at 37°C for 24 h.  In some 
experiments, cells were co-transfected with 2 μg of Rho GTPase (RhoA, Rac1, or 
Cdc42) cDNA and 4.5 μg of Asef2 siRNA #1, pSUPER vector, or scrambled 
siRNA cDNA.  Cell lysates were collected and assayed as previously described 
(Ren 1999).  Active GTPase assays were performed in HEK-293 cells as 
described above except in these experiments, cells were co-transfected with 1 μg 
GFP or GFP-Asef2 cDNA along with the tagged GTPases.   
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Results 
 
Asef2 increases the activity of Rac and Cdc42, but decreases the amount of 
active Rho 
 
 We recently developed a proteomics-based screen to search for proteins 
that regulate migration and actin dynamics (Mayhew, Webb et al. 2006).  One of 
the molecules that we detected was a 652 amino acid protein, Asef2 (Fig. 7A), 
which is reported to have GEF activity for Rac1 and Cdc42 (Kawasaki, Sagara et 
al. 2007).   Since the function of Asef2 in cell migration is not well understood, 
this provided us with an opportunity to study the role of this protein in regulating 
migration.  We began by examining the effects of Asef2 on Rho family GTPases 
by assaying for active Rac1, Cdc42, and RhoA in HEK-293 cells expressing GFP 
or GFP-tagged Asef2.  In these assays, GST-tagged binding domains from 
effectors are used to detect the active form of the GTPases.  As shown in Fig. 8, 
GFP-Asef2 expression increased the level of active Rac and Cdc42 by two-fold 
and 3-fold, respectively, which is consistent with Asef2 having GEF activity 
toward these GTPases (Kawasaki, Sagara et al. 2007).  Interestingly, RhoA 
activity was decreased by approximately two-fold in GFP-Asef2 expressing cells.  
These results indicate that Asef2 significantly affects the amount of active Rac, 
Cdc42, and RhoA in cells.   
  To study the function of Asef2 in regulating actin dynamics and cell 
migration, we generated HT-1080 cell lines stably expressing low levels of GFP-
Asef2 or GFP as a control.  In these cells, the level of GFP-Asef2 expression was  
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Figure 7. Asef2 increases the amount of active Rac1 and Cdc42, but 
decreases Rho activity in HT-1080 cells.  (A) Schematic of the domain 
structure of Asef2.  APC binding region (ABR), Src homology 3 (SH3), Dbl 
homology (DH), and Pleckstrin homology (PH) domains are shown.  (B) 
Immunoblot for Asef2 from HT-1080 cells stably expressing GFP-Asef2.  The ~ 
75 kDa band represents endogenous Asef2 while the ~100 kDa band 
corresponds to exogenously expressed GFP-Asef2.  (C) Quantification of the 
amount of GFP-Asef2 in stably expressing HT-1080 cells relative to endogenous 
levels of the protein.  Error bar represents S.E.M. from four separate 
experiments.  (D) The GTP bound (active) form of Rac1, Cdc42, and RhoA was 
pulled down from lysates of GFP (Control) or GFP-Asef2 stable cells.  The total 
amount of each of these GTPases in cells is included as a loading control.  
Quantification of the amount of active GTPases from blots from four separate 
experiments is shown in the lower panels.  Error bars represent S.E.M. (*, p < 
0.04; **, p < 0.003).   
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Figure 8.  Asef2 increases Rac1 and Cdc42 activity and decreases the 
amount of active Rho in HEK-293 cells.  The active form of Rac1, Cdc42, and 
RhoA was pulled down from lysates of HEK-293 cells expressing GFP (Control) 
or GFP-Asef2.  The total amount of each of these GTPases in the cells is 
included as a loading control.  Quantification of the amount of active Rac1, 
Cdc42, and Rho in HEK-293 cells expressing GFP (Control) or GFP-Asef2 is 
shown (lower panels).  Error bars represent S.E.M. from at least three separate 
experiments.  Asterisks denote statistically significant differences when 
compared with control GFP expressing cells (p < 0.0001). 
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< 3-fold over endogenous Asef2 as determined by Western blot analysis (Fig. 7B 
and C). The amount of active Rac and Cdc42 was increased 1.5-fold while active 
RhoA was decreased greater than two-fold in GFP-Asef2 stably expressing HT-
1080 cells compared with control cells expressing GFP (Fig. 7D), which is 
consistent with the results obtained in the HEK-293 cells.  Thus, these cells 
provided us with stable cell lines for examining the effects of Asef2 on migration 
and were used in subsequent experiments.  
 
Asef2 localizes with actin at the leading edge of cells and regulates 
migration   
 Asef2 was previously reported to localize in membrane ruffles at the 
leading edge of HeLa cells (Sagara, Kawasaki et al. 2009), which is consistent 
with it playing an important role in regulating migration. In our study, endogenous 
Asef2 localized with actin at the leading edge of wild-type HT-1080 cells (Fig. 
9D), suggesting that Asef2 may indeed function to regulate HT-1080 cell 
migration via modulation of the actin cytoskeleton.  Like endogenous Asef2, 
GFP-Asef2 localized with actin at the leading edge while GFP alone was found to 
distribute diffusely throughout HT-1080 cells (Fig. 9A and C).  To confirm the 
enrichment of GFP-Asef2 at the leading edge, we measured the background 
subtracted, integrated fluorescence intensity at the edge of GFP and GFP-Asef2 
stable cells and normalized it to the unit area.  Indeed, the normalized leading  
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edge fluorescent intensity was significantly enhanced in GFP-Asef2 cells 
compared with control cells expressing GFP (Fig. 9B), indicating GFP-Asef2 is 
enriched at the leading edge.  Furthermore, these results show GFP-Asef2 
localizes similarly to the endogenous molecule and is a valid marker for 
examining Asef2 function. 
 The leading edge localization of Asef2 led us to hypothesize that it 
functions in the regulation of cell migration.  To test this, we assayed the effects 
of Asef2 on migration using live-cell imaging.   Fig. 9E shows individual migration 
tracks of GFP and GFP-Asef2 stable cells.  Interestingly, the migration paths of 
GFP-Asef2 stable cells were significantly longer than those in control cells (Fig. 
8E and F; Movies 1 and 2).  The migration velocity of GFP-Asef2 stable cells was 
increased 1.6-fold compared with control GFP stable cells (Fig. 9E), suggesting 
Asef2 regulates the migration of HT-1080 cells. 
 
Knockdown of endogenous Asef2 in HT-1080 cells decreases migration 
 To further explore the role of Asef2 in regulating migration, we generated 
two small interfering RNA (siRNA) constructs to knock down endogenous 
expression of the protein.  Transfection of wild-type HT-1080 cells with the two 
siRNA constructs resulted in a significant decrease in the expression of 
endogenous Asef2.  As determined by Western blot analysis, Asef2 siRNA #1 
knocked down endogenous expression of the protein by almost 65% and Asef2 
siRNA #2 decreased expression by approximately 50% compared with empty 
pSUPER vector (Fig. 10A and B).  In contrast, transfection with scrambled siRNA 
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did not significantly affect expression of endogenous Asef2.   Thus, the Asef2 
siRNAs were effective in decreasing expression of endogenous Asef2 and were 
used to assess the effect of Asef2 on migration.  Expression of the Asef2 siRNAs 
in wild-type HT-1080 cells resulted in an approximately two-fold decrease in the 
migration velocity compared with cells expressing scrambled siRNA or empty 
pSUPER vector (Fig. 10C and D; Movies 3 and 4).  To further show the decrease 
in migration was due to knockdown of Asef2, we performed a “rescue” 
experiment with Asef2 lacking the N-terminal ABR/SH3 domains (Asef2Δ204), 
which is an active form of Asef2 in terms of its GEF activity (Kawasaki, Sagara et 
al. 2007).  Since Asef2 siRNA #2 is designed against nucleotides within this N-
terminal region, it does not affect expression of Asef2Δ204.  Expression of 
Asef2Δ204 in cells transfected with Asef2 siRNA #2 led to a significant increase 
in the migration velocity, completely rescuing the defect in migration observed 
with Asef2 knockdown (Fig. 10C and D).  These results indicate that endogenous 
loss of Asef2 inhibits migration and point to a critical role for Asef2 in regulating 
this process.   
 Since our results suggested Asef2 regulates the activity of Rho family 
GTPases,   we assayed for active Rac, Cdc42, and Rho in cells in which 
endogenous Asef2 expression was knocked down.  Expression of Asef2 siRNA 
#1 led to a two-fold decrease in the amount of active Rac and Cdc42 compared 
to that observed in cells expressing scrambled siRNA or empty pSUPER vector 
(Fig. 10E).  In addition, RhoA activity was increased 1.7-fold in Asef2-knockdown 
cells compared with control cells expressing either scrambled siRNA or pSUPER  
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Figure 10.  Knockdown of endogenous Asef2 significantly impairs 
migration.  (A) Wild-type HT-1080 cells were transfected with empty pSUPER 
vector, scrambled siRNA (scr siRNA), or Asef2 siRNAs. In some experiments, 
wild-type HT-1080 cells were co-transfected with Asef2 siRNA #2 and a 
truncated form of Asef2 (Asef2Δ204) (right panels). Cell lysates were 
immunoblotted for Asef2 or α-tubulin (loading control). (B) Quantification of 
endogenous amounts of Asef2 from cells transfected with the indicated 
constructs is shown.  Error bars represent S.E.M. from four independent 
experiments (*, p < 0.0001).  (C) Wild-type HT-1080 cells were transfected with 
empty pSUPER vector, scrambled siRNA (scr siRNA), or Asef2 siRNAs and used 
in live-cell migration assays three days later.  To show the migration phenotype 
observed with Asef2 siRNA expressing cells was due to endogenous loss of the 
protein, Asef2Δ204, which is a truncated, active form of Asef2, was co-expressed 
with Asef2 siRNA #2. Rose plots with individual migration tracks for cells 
expressing the indicated constructs are shown. (D) Quantification of the 
migration velocity of cells transfected with the constructs from panel C is shown.  
Error bars represent S.E.M. for 30-35 cells from four separate experiments (*, p < 
0.009). (E) HT-1080 cells were transfected with empty pSUPER vector, 
scrambled siRNA (scr siRNA), or Asef2 siRNA #1 and cell lysates were assayed 
for active Rac1, Cdc42, and RhoA. Quantification of the amount of active 
GTPases from blots from four separate experiments is shown in the lower 
panels.  Error bars represents S.E.M. (*, p < 0.003; **, p < 0.03). For panels B, D, 
and E, asterisks denote a statistically significant difference compared with 
pSUPER transfected cells. 
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Figure 10-- cont. 
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vector (Fig. 10E).  These results indicate Asef2 regulates the activity of Rho 
family GTPases.  
 
Asef2 regulates adhesion turnover 
 
 Since assembly and disassembly of adhesions at the leading edge are 
essential for migration and Rho family GTPases are involved in this process 
(Rottner, Hall et al. 1999; Webb, Donais et al. 2004; Nayal, Webb et al. 2006), 
we hypothesized that Asef2 affects migration by regulating adhesion turnover.  
To test this hypothesis, GFP and GFP-Asef2 stable cells were immunostained for 
two adhesion markers, paxillin and vinculin, and observed with total internal 
reflection microscopy (TIRF).  Adhesions in Asef2 stable cells were very small 
and located primarily around the cell perimeter usually within 1 μm of the leading 
edge (Fig. 11A).  In contrast, in control cells, numerous large adhesions were 
found throughout the cell body (Fig. 11A).  Since the smaller, peripherally located 
adhesions in Asef2 stable cells could be the result of enhanced adhesion 
turnover, we further explored this possibility. Adhesion turnover was 
quantitatively assessed by transfecting GFP and GFP-Asef2 stable cells with 
mCherry-paxillin and measuring the t1/2s for the assembly and disassembly of 
adhesions as previously described (Webb, Donais et al. 2004; Nayal, Webb et al. 
2006).  In Asef2 stable cells, the apparent t1/2 for adhesion assembly was 
decreased approximately two-fold compared with control cells, indicating 
adhesions were forming significantly faster in the Asef2 cells (Fig. 11B and C; 
Table 1; Movies 5 and 6).  Asef2 had a similar effect on the disassembly of  
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Figure 11.  Asef2 induces the formation of small, leading edge adhesions 
that turn over very rapidly. (A) GFP (Control) and GFP-Asef2 stable cells were 
immunostained for endogenous paxillin or vinculin and visualized with TIRF 
microscopy.  Bar, 10 μm. (B) GFP and GFP-Asef2 stable cells were transfected 
with mCherry-paxillin, plated on Fn, and imaged in red fluorescence. Time-lapse 
images show adhesions at the leading edge assemble and disassemble on a 
much more rapid time scale in GFP-Asef2 stable cells compared with control 
GFP cells (arrowheads). Bar, 5 μm. (C) Quantification of the apparent t1/2 for 
adhesion assembly and the t1/2 for adhesion disassembly is shown (*, p < 0.003). 
Error bars represent S.E.M from 15-23 individual adhesions in 4-6 cells from at 
least three independent experiments. 
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Table 1. Apparent t1/2 for adhesion assembly and t1/2 for adhesion 
disassembly in HT-1080 cells 
 
The t1/2s are reported as means ± S.E.M.  For each t1/2, measurements were 
obtained from 15-23 individual adhesions in 4-6 cells from at least three 
independent experiments. 
 
Construct 
expressed 
Apparent t1/2 (min) 
(adhesion assembly) 
t1/2 (min) 
(adhesion 
disassembly) 
 
GFP 3.3 +/- 0.5 7.2 +/- 0.9 
GFP-Asef2 1.8 +/- 0.2 1.7 +/- 0.3 
pSUPER 3.0 +/- 0.3 6.9 +/- 0.6 
scr siRNA 3.4 +/- 0.3 7.3 +/- 0.8 
Asef2 siRNA#1 6.4 +/- 1.1 10.1 +/- 0.7 
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adhesions since the t1/2 for adhesion disassembly was decreased greater than 4-
fold in GFP-Asef2 stable cells compared with control cells (Fig. 11B and C; Table 
1; Movies 5 and 6).  These results suggest that Asef2 increases the rate of 
adhesion turnover, which could contribute to its effects on migration.     
 To confirm a role for Asef2 in adhesion turnover, we knocked down 
endogenous expression of the protein in wild-type HT-1080 cells with our siRNA 
construct.  Many large adhesions were found throughout cells expressing Asef2 
siRNA #1 (Fig. 12A).  These adhesions appeared to be bigger than those 
observed in control cells expressing scrambled siRNA (Fig. 12A), which 
prompted us to quantify adhesion turnover in Asef2-knockdown and control cells.  
Expression of Asef2 siRNA #1 resulted in a two-fold increase in the apparent t1/2 
for adhesion assembly compared to that observed in control cells expressing 
empty pSUPER vector or scrambled siRNA (Fig. 12B and C; Table 1).  Similarly, 
knockdown of endogenous Asef2 significantly increased the t1/2 for adhesion 
disassembly when compared with that observed in cells expressing either empty 
pSUPER vector or scrambled siRNA (Fig. 12B and D; Table 1).  Thus, 
knockdown of endogenous Asef2 significantly altered the rate of adhesion 
turnover, indicating it is an important regulator of this process.    
 
Rac, but not Cdc42, is essential for Asef2-mediated migration and adhesion 
turnover   
 
 Since our results show GFP-Asef2 stable cells have increased levels of 
both Rac and Cdc42, this raised the question as to which of these GTPases is 
critical for the Asef2-mediated effects on migration and adhesion dynamics.  To  
 64
  
 
 
 
 
 
 
 
Figure 12.  Knockdown of endogenous Asef2 affects adhesion turnover. (A) 
Wild-type HT-1080 cells transfected with scrambled siRNA (scr siRNA) or Asef2 
siRNA #1 were immunostained for endogenous paxillin or vinculin and visualized 
with TIRF microscopy. Bar, 10 μm. (B) Wild-type HT-1080 cells were co-
transfected with mCherry-paxillin and empty pSUPER vector, scrambled siRNA 
(scr siRNA), or Asef2 siRNA #1 and adhesion assembly and disassembly were 
assessed.  Time-lapse images show adhesions turn over more slowly in cells 
transfected with Asef2 siRNA #1 as compared with control cells transfected with 
either empty pSUPER vector or a scrambled siRNA (arrowheads). (C, D) 
Quantification of the apparent t1/2 for adhesion assembly (panel C) and the t1/2 for 
adhesion disassembly (panel D) is shown.  Error bars represent S.E.M from 15-
23 individual adhesions in 4-6 cells from at least three independent experiments 
(*, p < 0.006). Asterisks denote a statistically significant difference compared with 
pSUPER transfected cells. 
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 address this question, we generated Rac1 and Cdc42-specific siRNA constructs 
to knock down endogenous expression of the proteins and examined their effects 
on Asef2-mediated migration and adhesion turnover.  Rac siRNA #1 and Rac 
siRNA #2 decreased endogenous expression of Rac by approximately 75% 
compared with empty pSUPER vector or scrambled siRNA (Fig. 13A).  When the 
Rac siRNAs were transfected into GFP and GFP-Asef2 stable cells, an overall 
decrease in the migration velocity was observed (Fig. 13C and E), because Rac 
is an important regulator of cell migration.  More importantly, expression of the 
Rac siRNAs completely abrogated the Asef2-mediated effects on migration (Fig. 
13C and E).  The migration velocities were almost identical in GFP and GFP-
Asef2 stable cells transfected with the Rac siRNAs (Fig. 13E), indicating 
knockdown of endogenous Rac inhibited Asef2-mediated migration.  In contrast, 
scrambled siRNA had no effect on Asef2-mediated migration. 
 Since Asef2 also increased Cdc42 activity in HT-1080 cells, we examined 
the effects of Cdc42 on Asef2-mediated migration using an siRNA approach.  
When Cdc42 siRNA #1 or Cdc42 siRNA #2 were transfected into HT-1080 cells, 
endogenous expression of Cdc42 was decreased by almost 75% compared with 
empty pSUPER vector or scrambled siRNA (Fig. 13B).  Thus, the effectiveness 
of the Cdc42 siRNAs in decreasing endogenous expression of the protein was 
similar to that observed with the Rac siRNAs (Fig. 13A and B).  As with the Rac 
siRNAs, transfection of GFP and GFP-Asef2 stable cells with the Cdc42 siRNAs 
resulted in an overall decrease in the migration velocity (Fig. 13D and F).   
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Figure 13.  Rac, but not Cdc42, is necessary for the Asef2-mediated effect 
on migration. (A) Wild-type HT-1080 cells were transfected with empty pSUPER 
vector, scrambled siRNA (scr siRNA), or Rac siRNAs. Three days later cells 
were lysed and immunoblotted for Rac or actin (loading control). Quantification of 
the amount of endogenous Rac from blots of cells transfected with the indicated 
constructs is shown (lower panels). Error bars represent S.E.M. from four 
independent experiments (*, p < 0.0001). (B) HT-1080 cells were transfected with 
empty pSUPER vector, scrambled siRNA (scr siRNA), or Cdc42 siRNAs.  After 
three days, cell lysates were immunoblotted for Cdc42 or α-tubulin (loading 
control). Quantification of endogenous levels of Cdc42 from blots of cells 
transfected with the indicated constructs is shown (lower panels). Error bars 
represent S.E.M. from four independent experiments (*, p < 0.0001). For panels 
A and B, asterisks denote a statistically significant difference compared with 
pSUPER transfected cells. (C, D) GFP and GFP-Asef2 stable cells were 
transfected with empty pSUPER vector, scrambled siRNA (scr siRNA), Rac or 
Cdc42 siRNAs and used in migration assays. Rose plots with individual migration 
tracks are shown for cells expressing Rac siRNAs (panel C) or Cdc42 siRNAs 
(panel D). (E, F) Quantification of the migration velocity of cells transfected with 
the indicated constructs is shown. Error bars represent S.E.M. for 30-35 cells 
from four separate experiments (panel E *, p < 0.0001; panel F *, p < 0.0002). 
For panels E and F, asterisks denote statistically significant differences 
compared with GFP (Control) stable cells. 
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 Figure 13—cont. 
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 However, unlike the Rac siRNAs, expression of the Cdc42 siRNAs did not 
eradicate the Asef2-mediated effects on migration (Fig. 13D and F).  The 
migration velocity of GFP-Asef2 stable cells was still increased 1.5-fold 
compared with control cells when both cell lines were transfected with Cdc42 
siRNAs, indicating knockdown of endogenous Cdc42 did not significantly affect 
Asef2-mediated migration. 
 To further confirm that Cdc42 is not involved in Asef2-mediated migration, 
we treated GFP and GFP-Asef2 stable cells with the Cdc42-specific inhibitor 
secramine A (2.5 μM) (Pelish, Peterson et al. 2006; Xu B 2006).  Secramine A 
treatment resulted in an overall decrease in the migration velocity, but no effect 
was observed on Asef2-mediated migration.  The migration velocity of GFP and 
GFP-Asef2 stable cells treated with secramine A was 22.1 +/- 2.2 μm/h and 36.8 
+/- 2.9 μm/h (n= 12 from 4 separate experiments; p=0.0005), respectively.  
These results further establish that Rac, but not Cdc42, is necessary for Asef2-
promoted migration. 
 Since our results indicated that Asef2 regulated migration through Rac, we 
next determined whether the Asef2-mediated effects on adhesion turnover were 
also Rac-dependent.  When GFP and GFP-Asef2 stable cells were transfected 
with empty pSUPER vector or scrambled siRNA, the apparent t1/2 for adhesion 
assembly was decreased two-fold in GFP-Asef2 cells compared with control GFP 
cells (Table 2).  However, transfection of these cells with Rac siRNA #1  
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Table 2. Effect of endogenous Rac1 knockdown on Asef2-mediated 
adhesion assembly and disassembly. 
 
The t1/2s are reported as means ± S.E.M.  For each t1/2, measurements were 
obtained from 15-18 individual adhesions in 4-6 cells from at least three 
independent experiments. 
 
Constructs Expressed 
Apparent t1/2 (min) 
(adhesion 
assembly) 
t1/2 (min) 
(adhesion 
disassembly) 
GFP + pSUPER 3.6 +/- 0.3 7.0 +/- 0.9 
GFP + scr siRNA 3.5 +/- 0.4 7.1 +/- 0.9 
GFP + Rac1 siRNA#1 6.9 +/- 0.4 8.4 +/- 0.9 
GFP-Asef2 + pSUPER 1.7 +/- 0.2 1.8 +/- 0.2 
GFP-Asef2 + scr siRNA 1.7 +/- 0.3 1.7 +/- 0.2 
GFP-Asef2 + Rac1 siRNA#1 7.2 +/- 0.8 7.4 +/- 0.9 
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completely abrogated the Asef2-mediated effect on adhesion assembly and no 
significant difference in the apparent t1/2 for the assembly of adhesions was 
observed between GFP and GFP-Asef2 stable cells (Table 2).  As with migration, 
the knockdown of endogenous Rac affected the overall rate of adhesion 
assembly.  Similarly, the Asef2-mediated effect on adhesion disassembly was 
eradicated by knockdown of endogenous Rac.  A 4-fold decrease in the t1/2 for 
adhesion disassembly was observed in GFP-Asef2 stable cells compared with 
controls cells transfected with either empty pSUPER vector or scrambled siRNA 
(Table 2).  In contrast, when these cells were transfected with Rac siRNA #1, the 
t1/2 for adhesion disassembly was similar in GFP and GFP-Asef2 stable cells 
(Table 2).  Taken together, these results indicate Rac is necessary for the Asef2-
mediated effects on adhesion turnover and support our hypothesis that Asef2 
regulates migration and adhesion dynamics through a Rac-dependent 
mechanism. 
      
PI3K plays an important role in Asef2-mediated migration and adhesion 
turnover  
 Since PI3K is implicated in the modulation of cell migration and Rho family 
signaling (for review see (Cain and Ridley 2009)), we hypothesized it is a 
component of the Asef2 pathway that regulates migration and adhesion turnover.  
To examine the effects of PI3K on Asef2-mediated migration, GFP and GFP-
Asef2 stable cells were treated with various concentrations of the PI3K inhibitor 
wortmannin (Wymann 1996) for 30 min prior to imaging and then, migration was  
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Figure 14-- cont. 
 
 
 
Figure 14  PI3K is necessary for Asef2-mediated migration. (A) GFP 
(Control) and GFP-Asef2 stable cells were incubated with vehicle (DMSO), 
wortmannin, or LY294002 (50 M) and then used in live-cell migration assays. 
Rose plots with individual migration tracks are shown. (B) Quantification of the 
migration velocity of GFP (Control) and GFP-Asef2 stable cells treated with 
DMSO, wortmannin, or LY294002 is shown.  Error bars represent S.E.M. for 30-
35 cells from four separate experiments (*, p < 0.0001). (C) GFP (Control) and 
GFP-Asef2 stable cells were treated with vehicle (DMSO) or 10 nM wortmannin 
for 2 h and then cell lysates were assayed for active Rac. (D) Quantification of 
blots from five separate experiments is shown. Error bar represents S.E.M. (*, p 
< 0.0001). For panels B and D, asterisks denote statistically significant 
differences compared with GFP (Control) stable cells. 
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assessed.  Since PI3K contributes to the regulation of cell migration, treatment 
with wortmannin resulted in a dose-dependent decrease in the migration velocity 
(Fig. 14A and B).  Significantly, wortmannin treatment had a profound effect on 
the Asef2-promoted increase in migration.  The lower dose of wortmannin (5 nM)  
almost entirely abrogated the Asef2-mediated effect on migration since the 
migration velocities were almost identical in GFP and GFP-Asef2 stable cells 
(Fig. 14B).  Treatment of GFP-Asef2 stable cells with a higher concentration of 
wortmannin (10 nM) completely negated the Asef2-promoted increase in 
migration.  To confirm that PI3K is necessary for the Asef2-mediated effect on 
migration, GFP and GFP-Asef2 stable cells were treated with another PI3K 
inhibitor, LY294002 (50 μM) for 1 h and then migration was assessed.  Like 
wortmannin, LY294002 treatment led to a decrease in the migration velocity of 
both GFP and GFP-Asef2 stable cells, and importantly, treatment with LY294002 
completely abrogated the Asef2-promoted increase in migration (Fig. 14A and B).  
These results indicate that PI3K is required for Asef2-promoted migration.   
 Since Asef2-mediated migration was dependent on PI3K, we next 
determined whether PI3K was part of the Asef2 pathway regulating adhesion 
turnover.  GFP and GFP-Asef2 stable cells were treated with 10 nM wortmannin 
for 30 min prior to imaging and then, adhesion assembly and disassembly were 
assessed.  As with migration, wortmannin treatment significantly altered the t1/2s 
for adhesion assembly and disassembly in both cell types, which is consistent 
with PI3K playing a role in regulating adhesion turnover.  Notably, after 
wortmannin treatment, the t1/2s for adhesion assembly and disassembly in GFP-  
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Table 3. Effect of inhibition of PI3K on Asef2-mediated adhesion assembly 
and disassembly 
 
The t1/2s are reported as means ± S.E.M.  For each t1/2, measurements were 
obtained from 15-18 individual adhesions in 4-6 cells from at least three 
independent experiments. 
 
Treatment Apparent t1/2 (min) (adhesion assembly) 
t1/2 (min) 
(adhesion 
disassembly)  
GFP + DMSO 3.6 +/- 0.5 7.1 +/- 1.4 
GFP + wortmannin 9.1 +/- 1.1 13.5 +/- 1.7 
GFP + LY294002 6.8 +/- 0.6 8.9 +/- 0.9 
GFP-Asef2 + DMSO 1.9 +/- 0.2 1.6 +/- 0.4 
GFP-Asef2 + wortmannin 10.6 +/- 2.0 11.2 +/- 2.1 
GFP-Asef2 + LY294002 6.0 +/- 0.7 7.7 +/- 1.1 
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Asef2 stable cells were comparable to those observed in control GFP cells 
(Table 3).  Similar results were obtained when GFP and GFP-Asef2 stable cells 
were treated with LY294002 (Table 3), indicating inhibition of PI3K nullified the 
Asef2-promoted effect on adhesion turnover.  Taken together, these results 
suggest PI3K is essential for the Asef2-mediated regulation of cell migration and 
adhesion turnover.   
 Our results indicate PI3K and Rac are critical components by which Asef2 
regulates migration and adhesion dynamics; however, since PI3K can function 
upstream or downstream of Rac (Welch, Coadwell et al. 2003), it was unclear 
where PI3K acted.  To address this question, we inhibited PI3K activity in GFP 
and GFP-Asef2 stable cells by incubation with 10 nM wortmannin for 2 hours 
prior to lysis and then assessed the level of active Rac.  As expected, in the 
absence of wortmannin, the amount of active Rac was increased 1.5-fold in GFP-
Asef2 stable cells compared with control cells (Fig. 14C and D).  Even after 
wortmannin treatment, a 1.5-fold increase in the amount of active Rac was still 
observed in GFP-Asef2 stable cells compared with control cells.  Thus, inhibition 
of PI3K activity by wortmannin did not significantly affect the Asef2-promoted 
increase in the amount of active Rac, suggesting PI3K is not upstream of Rac in 
the Asef2 pathway regulating migration and adhesion turnover.   
 Since a Rac-PI3K-dependent mechanism is reported to be critical for the 
recruitment of some GEFs to the leading edge (Lin, Yang et al. 2006; Sjoblom, 
Jones et al. 2006), we inhibited PI3K activity and examined the effect on Asef2 
localization.  GFP-Asef2 stable cells were treated with LY294002 and the amount  
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Figure 15. Inhibition of PI3K does not affect the localization of GFP-Asef2 to 
the leading edge. GFP-Asef2 stable cells were treated with vehicle (DMSO) or 
LY294002 (50 μM) for 1 h and then fixed. Quantification of the normalized 
leading edge fluorescent intensity is shown. Error bars represent S.E.M. for 20 
cells from three separate experiments. 
 
 79
of Asef2 at the leading edge was quantified.  Treatment with LY294002 did not 
significantly affect the leading edge localization of Asef2 (Fig. 15).  Similar results  
were obtained when GFP-Asef2 stable cells were treated with wortmannin, 
indicating PI3K is not necessary for the recruitment of Asef2 to the leading edge. 
 
Akt is a component of the Asef2 pathway that regulates migration and 
adhesion turnover  
 
 Since the serine/threonine kinase Akt is activated downstream of PI3K 
(Franke, Yang et al. 1995), we hypothesized that it contributes to the Asef2-
mediated regulation of cell migration and adhesion turnover.  To test this, we 
immunostained for active Akt in GFP and GFP-Asef2 stable cells using a 
phospho-specific antibody against Thr308 as Akt is activated by phosphorylation 
of Thr308 and Ser473 (Bokoch 2003).  The level of active Akt co-localizing with 
actin at the leading edge of Asef2 stable cells was increased significantly 
compared with control cells (Fig. 16A).  When we quantified the normalized 
fluorescent intensity, we found greater than a 5-fold increase in the amount of 
active Akt at the leading edge of GFP-Asef2 stable cells compared with control 
cells (Fig. 16B). Interestingly, the total amount of Akt at the leading edge was 
also increased in Asef2 stable cells compared with control cells (Fig.17)  To 
further examine the role of Akt in Asef2-mediated migration, we transiently 
transfected GFP and GFP-Asef2 stable cells with a dominant negative (DN-Akt) 
or a kinase dead Akt mutant (KD-Akt) and analyzed their migration velocities.  
Both Akt mutants decreased the overall migration velocity; however, more  
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Figure 16.  Akt plays a role in Asef2-promoted migration. (A) GFP and GFP-
Asef2 stable cells were fixed and co-immunostained for active Akt using a 
phospho-specific antibody against Thr308 and actin with Alexa Fluor® 647-
phalloidin (false colored purple). (B) Quantification of the normalized fluorescent 
intensity of active Akt at the leading edge of GFP (Control) and GFP-Asef2 stable 
cells is shown. Error bars represent S.E.M. for 20 cells from three separate 
experiments (*, p < 0.0001). (C) GFP (Control) and GFP-Asef2 stable cells were 
transfected with DN-Akt, KD-Akt, or empty vector and used in live-cell migration 
assays.  Rose plots with individual migration tracks are shown. (D) Quantification 
of the migration velocity of GFP (Control) and GFP-Asef2 stable cells are shown. 
Error bars represent S.E.M. for 30-35 cells from three separate experiments (*, p 
< 0.0001). Asterisk denotes a statistically significant difference compared with 
GFP (Control) stable cells. 
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Figure 17. Asef2 increases the total amount of Akt at the leading edge. GFP 
and GFP-Asef2 stable cells were fixed and co-immunostained for total Akt using 
a pan-Akt antibody. Quantification of the normalized fluorescent intensity of total 
Akt at the leading edge of GFP (Control) and GFP-Asef2 stable cells is shown. 
Error bars represent S.E.M. for 15 cells from three separate experiments (*, 
p<0.0001). 
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 importantly, expression of DN-Akt or KD-Akt completely abolished the Asef2-
promoted increase in migration (Fig. 16C and D), suggesting the Asef2-mediated 
effect on migration is dependent on Akt.  We next generated two siRNA 
constructs to knock down endogenous expression of Akt and determined their 
effect on Asef2-mediated migration.  Akt siRNA #1 and Akt siRNA #2 decreased 
endogenous expression of the protein by 53% and 46%, respectively, compared 
with empty pSUPER vector or scrambled siRNA (Fig. 18A and B).  As with DN- 
and KD-Akt, expression of the Akt siRNAs in GFP and GFP-Asef2 stable cells 
completely abrogated the Asef2-mediated effect on migration (Fig. 18C and D).  
These results indicate Akt is essential for the Asef2-mediated regulation of cell 
migration. 
 Similarly, inhibition of Akt activity had a significant effect on adhesion 
turnover, suggesting a new role for Akt in regulating this process.  When GFP 
and GFP-Asef2 stable cells were transfected with KD-Akt or Akt siRNA #1, the 
Asef2-mediated effect on adhesion assembly and disassembly was eliminated 
(Table 4), indicating Akt is also critical for Asef2-promoted adhesion turnover.  
Taken together, our results suggest that Akt is necessary for the Asef2-mediated 
regulation of cell migration and adhesion turnover. 
 
Asef2-mediated regulation of Rho activity is important for cell migration 
 Our results showed a two-fold decrease in the level of active Rho in GFP-
Asef2 stable cells compared with control cells (Fig. 7D), which led us to  
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Figure 18. Knockdown of endogenous Akt significantly inhibits Asef2-
promoted migration. (A) Wild-type HT-1080 cells were transfected with empty 
pSUPER vector, scrambled siRNA (scr siRNA), or Akt siRNAs. Cell lysates were 
immunoblotted for Akt or α-tubulin (loading control). (B) Quantification of the 
amount of endogenous Akt in cells transfected with the indicated constructs. 
Error bars represent S.E.M. from four independent experiments (*, p < 0.0003). 
Asterisks denote a statistically significant difference compared with pSUPER 
transfected cells. (C) GFP (Control) and GFP-Asef2 stable cells were transfected 
with Akt siRNAs and used in live-cell migration assays. Rose plots with individual 
migration tracks are shown. (D) Quantification of the migration velocity of GFP 
(Control) and GFP-Asef2 stable cells transfected with the indicated constructs is 
shown. Error bars represent S.E.M. for 30-35 cells from three separate 
experiments (*, p < 0.0001). Asterisks denote statistically significant differences 
compared with GFP (Control) stable cells. 
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Table 4. Effect of kinase-dead Akt and Akt knockdown on Asef2-mediated 
adhesion assembly and disassembly 
 
The t1/2s are reported as means ± S.E.M.  For each t1/2, measurements were 
obtained from 15-18 individual adhesions in 4-6 cells from at least three 
independent experiments. 
 
Constructs Expressed Apparent t1/2 (min) (Adhesion Assembly) 
t1/2 (min) 
(Adhesion 
Disassembly) 
GFP + empty vector 3.1 +/- 0.5 6.7 +/- 1.0 
GFP + KD-Akt 7.6 +/- 0.9 7.2 +/- 1.2 
GFP + Akt siRNA #1 6.6 +/- 0.7 7.1 +/- 0.9 
GFP-Asef2 + empty vector 1.8 +/- 0.2 1.8 +/- 0.3 
GFP-Asef2 + KD-Akt 7.8 +/- 1.1 7.5 +/- 0.6 
GFP-Asef2 + Akt siRNA #1 5.7 +/- 0.7 7.1 +/- 0.8 
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hypothesize that Rho is an effector of the Asef2 pathway.  To test this 
hypothesis, we expressed constitutively active Rho (CA-Rho) in GFP and GFP-
Asef2 stable cells and examined the effect on migration.  If the Asef2-promoted 
increase in migration is due to a decrease in the amount of active Rho, then  
expression of CA-Rho should abrogate this migration phenotype.  Indeed, 
expression of CA-Rho in GFP-Asef2 stable cells eliminated the increased 
migration seen with these cells and their migration velocity was identical to that 
observed in control cells.  The migration velocities of GFP and GFP-Asef2 stable 
cells expressing CA-Rho were 10.8 +/- 1.4 μm/h and 10.8 +/- 1.3 μm/h (n= 20 
cells from three separate experiments), respectively, indicating expression of CA-
Rho eradicated the Asef2-promoted effect on migration.   
 We observed a 1.7-fold increase in RhoA activity and impaired migration 
in Asef2-knockdown cells, supporting our hypothesis that Asef2 regulates 
migration though Rho.  To demonstrate that the migration defect seen in Asef2-
knockdown cells was due to an increased amount of active Rho, we inhibited the 
activity of a Rho effector, Rho-associated kinase (ROCK) and examined the 
effect on migration.  As expected, expression of Asef2 siRNA #1 resulted in a 
two-fold decrease in the migration velocity compared with cells expressing 
scrambled siRNA or empty pSUPER vector (Fig. 19).  Treatment with the ROCK 
specific-inhibitor Y-27632 (10 μM) (Uehata, Ishizaki et al. 1997) led to an overall 
increase in the migration velocity of cells.  More significantly, Y-27632 treatment 
alleviated the migration defect observed with Asef2-knockdown cells and the 
migration velocity was increased almost 5-fold in these cells (Fig. 19).  Taken  
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Figure 19. Inhibition of ROCK activity eliminates the migration defect seen 
in Asef2-knockdown cells. Wild-type HT-1080 cells were transfected with 
empty pSUPER vector, scrambled siRNA (scr siRNA), or Asef2 siRNA #1. Three 
days later, cells were treated with vehicle (water), labeled “Control”, or Y-27632 
(10 μM) for 30 min and then used in live-cell migration assays. Error bars 
represent S.E.M. for 20 cells from three separate experiments (*, p < 0.0001; **, 
p < 0.0001). The “*” denote statistically significant differences compared with 
cells treated with vehicle. 
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together, these results suggest that Rho is an important effector by which Asef2 
regulates migration. 
 
Discussion 
 While it is well understood that Rho GTPase activity is regulated by GEFs, 
very little is known about the specific role GEFs play in regulating cellular 
processes, such as migration.  Our results show Asef2 coordinately regulates the 
activities of Rho family members to promote cell migration by stimulating the 
rapid turnover of adhesions.  Asef2 signaling leads to an overall decrease in the 
amount of active RhoA, which is critical for the effects of Asef2 on migration.  
RhoA induces the formation of stress fibers and can promote the maturation of 
nascent cell-matrix contacts into large, focal adhesions (Ridley and Hall 1992; 
Chrzanowska-Wodnicka and Burridge 1996; Rottner, Hall et al. 1999).  Thus, the 
loss of RhoA activity in Asef2 stable cells could inhibit the maturation of nascent 
adhesions and contribute to the more rapid turnover of these structures.  These 
described activities of Rho would be expected to inhibit migration.  Indeed, in 
some cell types, high levels of Rho have been shown to impede migration (Cox, 
Sastry et al. 2001). 
 Asef2 increases the activity of Rac1 and Cdc42, which is consistent with 
previous studies showing this molecule has GEF activity for these GTPases 
(Hamann, Lubking et al. 2007; Kawasaki, Sagara et al. 2007).   However, these 
studies did not detect an effect of Asef2 on RhoA.  This is most likely because 
Asef2 does not directly affect RhoA activity.  Our preliminary data indicate the 
 89
Asef2-mediated decrease in the amount of active RhoA is dependent upon Rac, 
PI3K, and Akt (data not shown).  The exact mechanism by which these 
molecules contribute to the inhibition of RhoA activity is currently unknown, but 
probably involves the regulation of Rho GEFs and/or GAPs, and represents an 
interesting avenue for future study.   
 Although Asef2 increases both Rac and Cdc42 activity, it regulates cell 
migration in a Cdc42-independent manner.  The role of Cdc42 in regulating 
migration is currently not fully understood and seems to be somewhat dependent 
on cell type.  In macrophages, Cdc42 is necessary for the response of these cells 
to a chemotactic gradient, but not for their migration (Allen, Zicha et al. 1998).  
Cdc42 is apparently not essential for directed migration of some cells since loss 
of this GTPase did not significantly affect the migration velocity of fibroblastoid 
cells in a wound closure assay (Czuchra, Wu et al. 2005).  In contrast, Cdc42-
deficient mouse embryonic fibroblasts exhibited a defect in their ability to migrate 
directionally and to respond to a chemotactic gradient (Yang, Wang et al. 2006).  
In our study, knockdown of Cdc42 in HT-1080 cells significantly decreased their 
migration velocity, suggesting Cdc42 does contribute to this process.  However, 
Cdc42 does not appear to play a significant role in Asef2-mediated random 
migration, but we cannot eliminate the possibility that Cdc42 is important for 
Asef2-promoted chemotaxis or directed migration.  Indeed, another Asef family 
member, Asef1, was recently shown to promote chemotaxis of HeLa cells toward 
hepatocyte growth factor in a trans-well assay (Kawasaki, Tsuji et al. 2009). 
While it is not clear whether Cdc42 plays a role in this process, PI3K appears to 
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be necessary for the Asef1-promoted effect on HeLa cell chemotaxis. Future 
studies will be needed to understand whether the Asef2-mediated increase in 
Cdc42 activity that we observed contributes to chemotaxis and directed 
migration.  
 The establishment of a Rac-PI3K feedback loop at the leading edge of 
cells is reported to be a mechanism for recruitment and activation of some GEFs 
(Lin, Yang et al. 2006; Sjoblom, Jones et al. 2006).  This indicates the regulation 
of GEF activity can be downstream of GTPase signaling.  While we cannot 
completely discount the possibility that this feedback loop occurs with Asef2, 
inhibition of PI3K activity by treatment with LY294002 or wortmannin did not 
significantly affect the membrane localization of Asef2, suggesting translocation 
of Asef2 to the plasma membrane is not PI3K-dependent.   
 Although Rac can be activated downstream of PI3K signaling (Hawkins, 
Eguinoa et al. 1995; Hooshmand-Rad, Claesson-Welsh et al. 1997; Cain and 
Ridley 2009), our results suggest that PI3K is not upstream of Rac in the 
mechanism by which Asef2 regulates migration.  One possibility is PI3K and Akt 
are downstream effectors of Rac in the Asef2 pathway that regulates cell 
migration.  Consistent with this, Rac has been shown to act upstream of PI3K 
signaling (Welch, Coadwell et al. 2002; Srinivasan, Wang et al. 2003; Cain and 
Ridley 2009).  Thus, the most likely scenario is that Asef2-promoted activation of 
Rac leads to an increase in PI3K and Akt activity. 
 Akt is well known for its role in modulating cell growth and survival, but 
more recently, there has been a growing interest in the function of Akt in 
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regulating cell migration.  In most cases, Akt stimulates the migration of epithelial 
cells, fibroblasts, and fibrosarcomas, including HT-1080 cells, but this function of 
Akt seems to be partially dependent on the isoform present (Kim, Kim et al. 2001; 
Irie, Pearline et al. 2005; Zhou, Tucker et al. 2006).  In our study, expression of 
Akt siRNAs, DN-Akt, or KD-Akt resulted in a decrease in the migration velocity, 
which is consistent with Akt promoting migration in HT-1080 cells (Kim, Kim et al. 
2001).  Interestingly, inhibition of Akt function led to a significant decrease in the 
turnover of nascent adhesions, which suggests a prominent, new role for Akt in 
regulating adhesion turnover.  Akt has several downstream effectors, including 
p21-activated kinase (PAK) and glycogen synthase kinase 3 β (GSK-3 β), which 
are known to regulate cell migration and actin dynamics.  The phosphorylation of 
PAK1 by Akt promotes the activation of this protein, which in turn, modulates 
reorganization of the actin cytoskeleton and thereby regulates migration (Bokoch 
2003; Yang, Tschopp et al. 2003).  Akt phosphorylation of GSK-3β on serine 9 
results in inactivation of this kinase which is important for the maintenance of a 
polarized migratory phenotype (Cross 1995; Etienne-Manneville and Hall 2003).   
 Our results point to a working model in which Asef2 stimulates cell 
migration through an increase in Rac activity.  A local increase in Rac activity can 
promote the formation of nascent adhesions at the leading edge.  At least one 
model for migration suggests it is important to keep Rho activity low at the 
leading edge of cells (Ridley, Schwartz et al. 2003).  The Asef2-induced 
decrease in Rho activity could impair the maturation of nascent adhesions into 
large, focal adhesions.  As a result, these adhesions do not mature into focal 
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adhesions, but instead turn over.  Highly motile cells, such as keratocytes and 
neutrophils, do not have large, well organized adhesions (Yuruker and Niggli 
1992; Lee and Jacobson 1997) while slower moving cells form larger, more 
mature adhesions (Couchman and Rees 1979).  It has been proposed that the 
turnover of small, dynamic, leading edge adhesions drives the rapid migration of 
cells (Nayal, Webb et al. 2006).  In this way, Asef2 could significantly enhance 
the migration velocity of cells by stimulating the rapid turnover of adhesions 
through the coordinated regulation of the Rho GTPases.  The Asef2-mediated 
regulation of migration and adhesion turnover are dependent on PI3K and Akt, 
which could contribute to these processes by modulating the activity of Rho 
GTPases.  
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CHAPTER IV 
 
ASEF2 INDIRECTLY INHIBITS RHO ACTIVITY 
 
Asef2 decreases Rho activity in a Rac-dependent manner 
 As discussed earlier, we found by active GTPase pull-down that Asef2 
increases Rac and Cdc42 activation by approximately two-fold, each. These data 
are supported by the findings of other groups that Asef2 binds to and activates 
both Cdc42 and Rac. These groups have also reported that Asef2 does not bind 
or activate Rho (Hamann, Lubking et al. 2007; Kawasaki, Sagara et al. 2007). 
However, our data show that Asef2 decreases the amount of active Rho in cells 
by two-fold. This led us to hypothesize that Rho is an effector of the Asef2/Rac 
pathway, and that Asef2’s activation of Rac indirectly inhibits Rho. In order to test 
this hypothesis, we used siRNA to knock down endogenous expression of Rac in 
both GFP and GFP-Asef2-expressing cells, and assessed the relative amounts 
of active Rho in these cells compared to controls. As a control, GFP and GFP-
Asef2-expressing cells were co-transfected with empty pSUPER vector and myc-
tagged Rho. When the amount of active Rho was assayed, we found a two-fold 
decrease in the Asef2-expressing cells compared to that in GFP cells.  In 
contrast, co-transfection of these cells with myc-Rho and Rac siRNA abolished 
the Asef2-mediated decrease in active Rho (Fig. 20A and B). Following siRNA-
mediated knockdown of endogenous Rac, GFP and GFP-Asef2 cells contained 
the same relative amount of active Rho. This strongly suggests that Rho is  
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Figure 20.  The Asef2-mediated decrease in Rho activity is dependent on 
active Rac. (A) GFP (Control) and GFP-Asef2 expressing cells were transfected 
with Rac siRNA #1 or empty pSUPER vector and cell lysates were assayed for 
active Rho.  (B) Quantification of blots as described in panel A is shown.  Error 
bars represents S.E.M. from four separate experiments (*, p < 0.003).  For panel 
B, asterisks denote statistically significant difference when compared with GFP 
(Control) expressing cells. 
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an effector of the Asef2/Rac pathway where it is inhibited by Asef2 in a Rac-
dependent manner. 
 
Asef2 activates Rac in a PI3K-independent manner 
 Our data indicate that Asef2 promotes migration and rapid adhesion 
turnover in a PI3K-dependent, Rac-dependent manner. We next examined 
whether PI3K activation was necessary for Asef2 to increase Rac activation. To 
assess the effect of PI3K activation on Asef2-promoted Rac activation, we 
transfected GFP control cells and GFP-Asef2-expressing HT-1080 cells with flag-
tagged Rac, then treated the cells for 2 h with the chemical PI3K inhibitor, 
wortmannin (10 nM), prior to lysis. In the absence of wortmannin (treated with 
DMSO alone), the amount of active Rac in Asef2 cells increased approximately 
two-fold over that in control cells. Interestingly, we found the same results in 
Asef2-expressing cells compared to controls following treatment with wortmannin 
(Fig. 21). These data suggest PI3K activation is not necessary for Asef2-
promoted Rac activation, but rather suggest that it may function elsewhere in the 
Asef2 pathway.  
 
Asef2 suppresses Rho activation through PI3K 
 To determine whether PI3K played a role in the observed Asef2-mediated 
decrease in Rho activation, we transfected GFP and GFP-Asef2-expressing cells 
with myc-Rho, then treated the cells with 10 nM wortmannin prior to lysis. The 
amount of active Rho was decreased significantly in GFP-Asef2-expressing cells  
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Figure 21.  The Asef2-mediated increase in Rac activity is independent of 
PI3K. (A) GFP (Control) and GFP-Asef2 expressing cells were treated with 
vehicle (DMSO) or 10 nM wortmannin and cell lysates were assayed for active 
Rac. (B) Quantification of blots as described in panel A is shown.  Error bar 
represents S.E.M. from five separate experiments (*, p < 0.0001). For panel B, 
asterisks denote statistically significant difference when compared with GFP 
(Control) expressing cells. 
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Figure 22. The Asef2-mediated decrease in Rho activity is dependent on 
PI3K. (A) GFP (Control) and GFP-Asef2 expressing cells were treated with 
vehicle (DMSO) or 10 nM wortmannin and cell lysates were assayed for active 
Rho.  (B) Quantification of blots as described in panel A is shown.  Error bar 
represents S.E.M. from five separate experiments (*, p < 0.0001).  For panel B, 
asterisks denote statistically significant difference when compared with GFP 
(Control) expressing cells. 
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compared with GFP control cells, when treated with DMSO alone (Fig. 22). 
However, treatment of GFP and GFP-Asef2-expressing cells with 10 nM 
wortmannin prior to lysis completely abolished the Asef2-promoted decrease in 
Rho activity. The amount of active Rho measured in control and Asef2-
expressing cells was similar when PI3K was inhibited, suggesting PI3K activity is 
necessary for Asef2-stimulated Rho inhibition. 
 
 
Asef2-promoted Rho suppression is Akt-dependent 
 Migration and adhesion turnover data also indicated Akt as an important 
member of the Asef2 pathway. Akt is commonly a downstream effector of PI3K, 
so having determined that Asef2’s regulation of Rho activity is PI3K-dependent, 
we next examined Akt’s role in this pathway. We used a kinase-dead mutant of 
Akt to determine whether Akt activation is necessary for Asef2-mediated Rho 
inhibition. The expression of KD-Akt had a similar effect to that of Rac 
knockdown and PI3K inhibition on the Asef2-promoted decrease of Rho 
activation. Consistent with our previous findings, GFP-Asef2 cells co-transfected 
with myc-Rho and empty vector (control) had significantly less active Rho than 
GFP cells under the same conditions. In contrast, GFP and GFP-Asef2-
expressing cells co-transfected with myc-Rho and KD-Akt had comparable 
amounts of active Rho. This indicates that the Asef2-mediated decrease of Rho 
activity is abrogated by Akt inhibition (Fig. 23), suggesting that Akt is a 
downstream effector of Asef2 in a pathway that leads to Rho inhibition.   
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Figure 23. The Asef2-mediated decrease in Rho activity is dependent on 
Akt. (A) GFP (Control) and GFP-Asef2 expressing cells were transfected with 
KD-Akt or empty vector and cell lysates were assayed for active Rho. (B) 
Quantification of blots as described in panel A is shown. Error bar represents 
S.E.M. from three separate experiments (*, p < 0.005). For panel B, asterisks 
denote statistically significant difference when compared with GFP (Control) 
expressing cells. 
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Summary 
 Here we offer evidence that Rho is a downstream effector of Asef2. Active 
GTPase pull-down assays were used to determine that Asef2 inhibits Rho 
activation in a Rac-dependent manner. Further, PI3K activation, which was 
earlier shown to play an important role in Asef2-mediated promotion of migration 
and rapid adhesion turnover, is not required for Asef2-promoted activation of 
Rac, but is necessary for Asef2-mediated Rho inhibition. Finally, Akt activation is 
also necessary for suppression of Rho activity by Asef2. As Akt frequently acts 
as a downstream effector of PI3K, it is likely to function similarly here.  
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CHAPTER V 
 
SUMMARY AND CONCLUSIONS 
 
Significance 
The research presented in this dissertation demonstrates that the Rho 
Family GEF, Asef2, functions as an important regulator of cell migration, and 
specifically, that it regulates the assembly and disassembly, or turnover, of cell-
matrix adhesions. This is of note, because it is thought that an optimal adherence 
of the cell to its substrate must be maintained for migration to proceed ideally, 
and tighter or looser adherence to the substrate typically leads to a defect in 
migration (Palecek, Huttenlocher et al. 1998). In this case, the decreased 
adherence to the substrate improves the cell’s ability to migrate. Here, we show 
that a rapid turnover of adhesions, promoted by Asef2, contributes significantly to 
increase random migration velocity.  
Asef2 increases the activation of Rac and Cdc42, but decreases Rho 
activation. Prior to this dissertation, Asef2 was shown to bind to and activate both 
Cdc42 and Rac, but appeared to have no effect on Rho activation. Further, the 
activation of Rac or Cdc42 seemed to occur separately in a cell type-specific 
manner. We did not find any evidence of cell-type specificity in the course of this 
body of work. In HEK 293 or HT-1080 cells, Asef2 was found to increase both 
Rac and Cdc42 while decreasing Rho activity, as demonstrated by our active 
GTPase pull-down assays, described previously. This suggests the possibility of 
 102
complex differential regulation of Asef2 in various cell types, but more 
importantly, the data presented here indicate an important role for Asef2 as an 
activator of Rac and Cdc42 as well as a negative regulator of Rho that had 
previously not been described.  
Moreover, the research presented in this dissertation suggests a 
mechanism by which the activation of Rac leads to the inhibition of Rho, thereby 
promoting rapid adhesion turnover. Although many pathways have been 
examined in which the antagonistic regulation of Rho by Rac and vice versa is 
well documented, this is the first evidence that Rac activation regulates adhesion 
turnover in particular by inhibiting Rho.     
Although PI3K and Akt are well-established as regulators of cell migration, 
specific mechanisms through which they function as such are not well described. 
Here, we offer evidence that PI3K and Akt function downstream of Asef2 to 
promote migration through a novel mechanism that involves the modulation of 
adhesions leading to their rapid assembly and disassembly. Furthermore, in this 
mechanism, PI3K and Akt function to negatively regulate Rho activation. Recent 
studies have implicated PI3K and Akt as important negative regulators of Rho 
activation (Kakinuma N 2008). However, these studies have revealed a 
mechanism by which these molecules decrease Rho activation to promote 
migration by disrupting stress fiber formation, but have not detected an effect on 
adhesion turnover. The data presented in this thesis suggest a novel role for Akt 
as an important regulator of adhesion dynamics, as well as providing a novel 
mechanism by which PI3K and Akt modulate Rho activity. 
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Asef2 is an important regulator of cell migration and, in particular, 
adhesion assembly and disassembly. It modulates these processes by 
increasing Rac activity and decreasing Rho activity. The role of Asef2-mediated 
Cdc42 activation is still not clear, but may be an important mechanism for 
regulating cell polarity and directional migration. Asef2 appears to indirectly 
inhibit Rho activation in a novel mechanism that requires increased Rac, PI3K, 
and Akt activity. This previously-undescribed mechanism functions to promote 
cell migration and rapid adhesion turnover, and suggests a possible role for 
Asef2 in pathological conditions such as cancer, where dysregulation of Asef2 
could potentially promote cancer cell metastasis.  
 
Summary 
 The work detailed in this dissertation began with a proteomics search for 
migration-related molecules by Donna Webb in which an unknown protein was 
pulled down from cell lysates in separate experiments by PAK and paxillin, and 
identified by mass spec. Analysis indicated the presence of PH, DH, and SH3 
domains within the protein, suggesting a probable role as a Rho Family GEF. At 
that time, there was nothing in the literature describing this molecule, and early 
work in the Webb lab determined it increased Rac and Cdc42 activity. Thus, it 
was termed CRAG for Cdc42 and Rac Activating GEF. After the identification of 
CRAG by the Webb lab and before the publication of this dissertation or any 
peer-reviewed research articles related to CRAG, two groups nearly 
simultaneously identified a Rho Family GEF called Asef2 in a database search 
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for molecules with homology to Asef (now Asef1). The first data identifying Asef2 
was published in 2007 (Hamann, Lubking et al. 2007; Kawasaki, Sagara et al. 
2007). It has since been determined by sequence analysis that CRAG and Asef2 
are one and the same. Fortunately, the data published by others on Asef2 does 
not overlap significantly with that presented in this dissertation. 
 As a regulator of Rho GTPases, Asef2 was thought to be a potential 
regulator of cell migration, and the data in this dissertation strongly supports this 
hypothesis. Like GFP-Asef2, endogenous Asef2 co-localizes with actin at the 
leading edge of migrating cells. This localization not only suggests Asef2 may be 
interacting with actin, even if only indirectly, but is also similar to localization of 
known actin modulators and other molecules known to regulate migration. 
Using an active GTPase pull-down assay, we have shown that Asef2 
increases the amount of active Cdc42 and Rac significantly in both HEK 293 and 
HT-1080 cell lines. This is supported by data recently published by Kawasaki et 
al. (2007) and Hamann et al. (2007) showing that Asef2 binds to and activates 
Cdc42 and Rac in vitro and in cell lines. However, these studies found Asef2-
mediated activation of Rac and Cdc42 occurred in a cell type-specific manner.  
Our data indicate Asef2 is capable of increasing activation of both GTPases in 
HEK 293 and HT-1080 cell lines to approximately the same degree. However, 
none of the previous studies included either of these cell lines. Also of note, data 
presented in this study indicate that Asef2 is capable of decreasing the amount of 
active Rho in cells. This was not previously discovered, probably because other 
groups who have investigated Asef2 tested direct activation of GTPases by 
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Asef2 in biochemical in vitro assays. An indirect inhibition of Rho by Asef2 via a 
downstream pathway would not be detected in such a manner. As an activator of 
Cdc42 and Rac and an inhibitor of Rho, Asef2 has great potential to play an 
important role as a regulator of cell migration and its underlying processes. 
 Previous studies have shown that Asef2 expression increases migration 
of MDCK and HeLa cells in a trans-well assay, but little else is known about 
Asef2-mediated effects on migration (Kawasaki, Sagara et al. 2007). Data 
presented in this thesis support previous findings, as MCF-7 human carcinoma 
cells transiently transfected with GFP-Asef2 exhibited increased migration in a 
trans-well assay compared to control cells expressing GFP alone (Figure 24). 
Furthermore, Asef2 promotes undirected migration, and this is evident from data 
collected in random migration assays. HT-1080 cells expressing low levels of 
GFP-Asef2 migrate 1.5-fold faster on average than GFP control cells on a Fn 
substrate. The specificity of Asef2’s role in this increased migration effect is 
confirmed by siRNA-mediated knockdown of endogenous Asef2 in HT-1080 
cells. Asef2 knockdown significantly decreases the migration velocity, compared 
to HT-1080 cells expressing empty vector or scrambled siRNA, which lack any 
migration defects. This migration defect is completely rescued with the 
expression of constitutively active Asef2, supporting the hypothesis that Asef2 is 
an important regulator of cell migration. 
Asef2 also increases migration of cells into a scratch-wound, which is an 
indicator that Asef2 may play an important role in directional migration, since the 
cell monolayer is migrating generally in one direction—into the wound (Fig. 25). 
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The ability of Asef2-expressing cells to fill a scratch-wound faster than control 
cells are able to fill a similarly sized wound is the result of Asef2-mediated 
enhanced migration, and not due to differences in cell proliferation. Since Cdc42 
is attributed with regulating cell polarity and directional migration, it would be 
interesting to determine whether these data are the result of an Asef2-mediated 
increase of Cdc42 activation. Clearly, Asef2 is an important regulator of 
migration, and these data suggest it may affect both random and directional 
migration. However, the act of migration is a multi-step process, and these 
random migration and scratch-wound assays have not offered adequate insight 
into Asef2’s role in regulating the individual steps involved in migration, such as 
adhesion assembly and disassembly.   
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Figure 24. Asef2 increases MCF-7 cell migration through a trans-well.  
Transiently transfected MCF-7 cells expressing GFP-Asef2 traversed a trans-well 
membrane more effectively than GFP-expressing controls. The number of 
migrating cells was normalized according to the transfection efficiency. The 
average number of control cells able to pass through the trans-well was set to 
100%. (Control cells, 100% +/- 8.6; GFP-Asef2 cells, 194.4% +/- 14.7; n=11-12 
wells from 3 separate experiments; * p<0.0001)  
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Figure 25. Asef2 promotes scratch-wound closure. A confluent monolayer of 
GFP (control) and GFP-Asef2 stably expressing HT-1080 cells was “wounded” to 
generate an area denuded of cells.  Time-lapse images were collected as the 
cells migrated to close the wound and images from the time-lapse movies are 
shown.  Bar, 100 μm.  Quantification of the migration velocity at the wound edge 
is shown (far right).  Error bars represent S.E.M. for 42-56 data points from three 
separate experiments. * p<0.0001.   
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  The antagonistic relationship between Rac activation and Rho inhibition 
has been well established over the years. As discussed earlier, Asef2 increases 
Rac activation and decreases Rho activity. This suggests an intriguing possible 
role for Asef2 as a player in the push-pull relationship between these molecules. 
Asef2 increases migration, and it has a curious effect on Rac and Rho activity. 
Both of these GTPases have been associated with the formation of cell-matrix 
adhesions, and are important regulators of adhesion turnover. This led us to ask 
whether Asef2 regulates adhesion dynamics, so we compared TIRF images of 
GFP-Asef2 cells stained for paxillin or vinculin to visualize adhesions with control 
cells under the same conditions. Adhesions in GFP-Asef2 cells were localized 
primarily at the perimeter of the cell, and were considerably smaller than those in 
control cells, which had several larger adhesions spread throughout the cell 
body. Quantification of this phenomenon was achieved with use of an adhesion 
turnover assay in which individual adhesions in a time-lapse movie were 
observed as they assembled and disassembled over time. A striking difference in 
the apparent t1/2 of adhesion assembly and the t1/2 of adhesion disassembly was 
observed in cells expressing GFP-Asef2 compared to control cells. Adhesions 
assembled in Asef2 cells 1.8-fold faster and disassembled 4.4-fold faster than 
those in control cells. These data are strongly supported by the significant 
increase in apparent t1/2 of adhesion assembly and t1/2 of adhesion disassembly 
in wild-type HT-1080 cells that occurs when endogenous Asef2 is knocked down 
by siRNA. Not surprisingly, adhesions in Asef2-knockdown cells appear larger 
and more abundant than those in control cells, as seen by TIRF microscopy. 
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Taken together, these data implicate Asef2 as an important regulator of adhesion 
turnover. 
Others have shown that Asef2 binds to and activates Rac, as discussed 
previously, and data presented in this study support this—Rac activation is 
increased by Asef2 expression in HEK 293 and HT-1080 cells. Since cells 
expressing Asef2 have enhanced migration and increased levels of active Rac, 
we hypothesized Asef2 may promote migration in a Rac-dependent mechanism. 
Two Rac-specific siRNA constructs were expressed in Asef2 and GFP cells 
individually, and indeed, Rac knockdown not only decreased the migration 
velocity of both cell lines compared to empty vector and scrambled siRNA 
controls, but it abolished the Asef2-mediated migration advantage. Cells treated 
with Rac-siRNA all migrated at the same velocity, regardless of Asef2 
expression. These data support a mechanism by which Asef2 increases Rac 
activity to promote cell migration. 
In contrast, Asef2-mediated activation of Cdc42 does not function as a 
random migration-promoting mechanism. Expression of Cdc42-specific siRNA in 
Asef2-expressing and GFP control cells failed to eliminate the Asef2-mediated 
increase in migration velocity. Although there was an overall decrease in the 
absolute velocities of both cell lines, the Asef2-expressers were still significantly 
faster than control cells under the same conditions. Treatment with the Cdc42-
specific chemical inhibitor, secramine A, confirmed these findings. Taken 
together, these data strongly suggest Asef2-promoted random migration is Rac-
dependent, but Cdc42-independent. This is not surprising, as Cdc42 is typically 
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associated with filopodial formation, establishment and maintenance of cell 
polarity, and directional migration, rather than undirected migration. 
As Cdc42 does not appear to regulate Asef2-mediated migration, we 
chose to look elsewhere for potential downstream targets of Asef2 that may 
regulate rapid adhesion turnover. Rac is well established as a regulator of 
adhesion dynamics. As an activator of Rac and an important regulator of 
adhesion dynamics, Asef2 is likely to regulate adhesions in a mechanism that 
involves Rac activation. Analysis of adhesion turnover in Asef2-expressing cells 
treated with Rac-specific siRNA, compared to control cells under the same 
conditions revealed that Asef2 promotes adhesion turnover in a Rac-dependent 
manner.  
Molecular regulators of cell migration other than Rho GTPases were 
examined as potentially integral players in the Asef2 pathway. Inhibition of PI3K 
with wortmannin or LY294002 in control and GFP-Asef2 cells decreased 
migration overall, but importantly, cells expressing Asef2 no longer migrated any 
more rapidly than control cells. Like Rac, PI3K activation is required for Asef2-
mediated migration. In addition, adhesion turnover in both Asef2 and control cells 
is drastically slowed to the same apparent t1/2 of assembly and t1/2 of disassembly 
in both cell lines when PI3K is inhibited, demonstrating a dependence of Asef2-
promoted adhesion turnover on PI3K activation.  
As a well-established downstream effector of PI3K with a known ability to 
affect cell migration, Akt is another molecule we deemed likely to interact with 
members of the Asef2 pathway in a manner that could affect migration and 
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adhesion dynamics. We found that GFP-Asef2-expressing cells, unlike GFP-
expressing controls, have an enrichment of active Akt at the leading edge that 
co-localizes with Asef2 and actin, as indicated by immunofluorescence.  Not 
surprisingly, expression of kinase-dead or dominant negative Akt mutants or Akt 
siRNA in control and Asef2-expressing cells caused a global decrease in 
migration velocity in both cell lines and abolished the Asef2-mediated increase in 
migration velocity seen previously. Therefore, Akt is also an important regulator 
of Asef2-mediated adhesion turnover, apparent by significantly slowed turnover-- 
both assembly and disassembly-- seen in Asef2 and control cells expressing KD-
Akt or Akt siRNA. As was demonstrated previously with Rac and PI3K, disrupting 
Akt function abrogates Asef2-mediated effects on adhesion dynamics. 
Previously, we found that Asef2 decreases Rho activity in cells, and 
hypothesized that this Rho inhibition may be integral to the observed Asef2-
mediated enhanced migration. We confirmed this by circumventing Asef2’s 
effects on Rho with the expression of a constitutively-active form of Rho (CA-
Rho), which decreased the observed migration velocities of GFP control cells 
and Asef2 cells equally. Further, we treated Asef2-knockdown cells with the Rho-
associated kinase (ROCK)-specific inhibitor, Y-276362, and saw a complete 
alleviation of the migration defects previously seen in cells treated with Asef2 
siRNA. Indeed, Rho inhibition appears to be an important aspect of Asef2-
mediated migration. 
Data presented in this dissertation offer some insight to the molecular 
mechanism by which Asef2 promotes cell migration and adhesion turnover. 
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Having identified PI3K and Akt as important molecular regulators in the Asef2 
pathway, in addition to Rac, we sought to elucidate the relationship of these 
molecules to one another, and to clarify the mechanism by which Asef2 inhibits 
Rho.  Interestingly, we found that Asef2 continues to localize normally to the 
plasma membrane when PI3K is inhibited with wortmannin or LY294002. Using 
an active GTPase pull-down, we showed that PI3K activation, while necessary 
for Asef2-mediated migration and adhesion regulation, is not necessary 
upstream of Rac in this pathway. Treating cells with wortmannin prior to active-
Rac pull-down had no effect on the relative amount of active Rac in Asef2 cells 
compared to controls. A similar experiment determined PI3K activation is 
required for Asef2-mediated Rho inhibition. Inhibition of PI3K by wortmannin 
alleviated the Asef2-mediated suppression of Rho activity seen in untreated cells. 
It is interesting to note that although the Asef2-mediated suppression of Rho 
activity is relieved by PI3K inhibition, overall Rho activity is decreased by 
wortmannin in control cells. This is likely a side-effect of global PI3K suppression 
in the cell, indicating multiple PI3K-mediated pathways may be responsible for 
Rho regulation in cells, some of which may lead to Rho activation.  
 As suggested earlier, it is possible Asef2-mediated activation of Rac could 
potentially lead to a downstream inhibition of Rho activity. Data presented here 
indicate this is indeed the case. By knocking down endogenous Rac with siRNA 
prior to pulling down active Rho, we have shown that Asef2-mediated Rho 
suppression is Rac-dependent. Cells expressing Rac siRNA have the same 
relative amount of active Rho, regardless of Asef2 expression. When taken 
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together with the data indicating PI3K acts in this pathway upstream of Rho, but 
not upstream of Rac, these data suggest a pathway in which Asef2 increases 
Rac activation upstream of PI3K activation, which leads to downstream Rho 
inhibition. 
To further elucidate this pathway, the effect of Akt activity on Asef2-
mediated Rho inhibition was assessed. As a downstream effector of PI3K with a 
known role in regulation of cell migration, it was not surprising that Akt activation 
was required for Asef2-mediated Rho inhibition. KD-Akt relieved Asef2-mediated 
suppression of Rho activity. While this identifies Akt as an important regulator of 
Asef2-mediated Rho inhibition, it does not identify Akt’s place in this pathway. It 
is, however, very appealing to suggest it lies just downstream of PI3K, where it is 
activated by a lipid product of PI3K. 
In summary, this dissertation describes the role of a recently identified 
Rho family GEF in regulating cell migration and begins to elucidate the molecular 
mechanism by which this GEF acts. Asef2 increases Rac and Cdc42 activation, 
but decreases Rho activity. Asef2 co-localizes with actin at the leading edge of 
cells and promotes random and directional migration and rapid adhesion 
turnover. Asef2’s effects on random migration are independent of Cdc42 
activation, but are dependent on Rac, PI3K, and Akt activation. Adhesion 
turnover is also promoted by Asef2 in a manner that depends upon activation of 
Rac, PI3K, and Akt (Fig. 26). Asef2-mediated activation of Rac is not PI3K-
dependent, but its inhibition of Rho is PI3K-dependent. Asef2-mediated inhibition 
of Rho is also dependent on Rac and Akt activation. These data suggest a novel  
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Figure 26. Predicted Asef2 model. An external stimulus activates integrin 
heterodimers, causing a signaling cascade that leads to Asef2 activation at the 
cell’s leading edge, when APC binds it and relieves Asef2 from its autoinhibitory 
conformation. Now active, Asef2 can bind GDP-bound Rac, causing a 
conformational change that allows Rac to release GDP and bind GTP, becoming 
active. Active Rac then stimulates the formation of nascent adhesions at the 
leading edge that stabilize extending membrane protrusions. Active Rac leads to 
the activation of PI3K via a currently unknown mechanism, which leads to Akt 
activation. It is predicted that p190 RhoGAP becomes activated downstream of 
PI3K and Akt, which then causes the observed inhibition of Rho activity. The 
inhibition of Rho prevents adhesion maturation, facilitating rapid adhesion 
turnover.     
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mechanism of adhesion turnover regulation, and implicate Asef2 as an important 
regulator of cell migration. 
  
Conclusions and Future Directions 
Data presented in this dissertation and by others indicate Asef2 increases 
Rac and Cdc42 activation. While Kawasaki et. al. (2007) and Hamann et. al 
.(2007) used in vitro biochemical analysis to determine binding and activation 
specificity of Asef2 for Cdc42 and Rac with no interaction or influence on Rho 
activity, we have shown that Asef2 increases Rac and Cdc42 activation and 
decreases Rho activity in cells. Others have concluded that Asef2 activates 
Cdc42 or Rac in a cell-type specific manner when examining HeLa or MDCK 
cells—something we did not experience in our work with HEK 293 or HT-1080 
cell lines. It would be interesting to determine Asef2-mediated GTPase activation 
in HEK and HT-1080 cells following stimulation with growth factors, such as 
PDGF or EGF or following monolayer wounding that may stimulate directional 
migration cues. Cells used for active GTPase pull-down assays were plated 
without a Fn substrate, and so adhered to ECM components secreted from the 
cells, themselves.  It is possible that perhaps the GTPase specificity of Asef2 is 
determined by the external stimulus, as the cell interprets individual signals into 
differing pathways to elicit the appropriate response to fit the cue.  
Cells expressing Asef2 migrate more rapidly than controls, whether in a 
trans-well, migrating randomly, or migrating to fill a scratch-wound. This supports 
data presented by others who examined the effect of Asef2 expression on the 
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ability of cells to migrate in a trans-well assay. The data presented in this thesis 
have been derived from experiments in which full-length Asef2 tagged with GFP 
has been stably transduced into cells or endogenous Asef2 was knocked down 
by siRNA. Previous studies by Kawasaki et. al. found similar results in a trans-
well assay when they expressed full-length, un-tagged Asef2 in MDCK cells. 
Interestingly, they reported further enhanced migration when they expressed a 
truncated mutant of Asef2 that lacks the ABR and SH3 domain, which leads to 
constitutive activation of Asef2. Additionally, Kawasaki et. al. found that Asef2 is 
an important regulator of cell migration in SW480 colorectal cancer cells that 
express a mutated APC associated with tumorigenesis. Migration data from this 
group in addition to that presented in this thesis implicate Asef2 as an important 
regulator of cell migration and suggest it may be important in pathological 
conditions by promoting tumorigenesis and cancer cell metastasis. Future 
experiments should include studies to determine the effect of APC-mediated 
Asef2 activation in HEK 293 and HT-1080 cells, as expression of full-length 
Asef2 alone significantly increased migration of these cell lines without regard to 
APC. Whether APC-mediated activation of Asef2 is strictly necessary for Asef2 to 
elicit a biological response in these cells remains unclear. It would be interesting 
to screen a variety of cell types and cancer cell lines to determine Asef2’s 
prevalence and correlate pathology with Asef2 or APC mutations that may lead 
to Asef2 dysregulation. 
  Asef2 is an important regulator of cell-matrix adhesion turnover. Its 
expression leads to rapid adhesion assembly and disassembly in cells, as 
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visualized by the incorporation of mCherry-paxillin into adhesions at the leading 
edge of lamellipodial protrusions and its elimination from adhesions as they 
disassemble. Asef2 promotes rapid turnover via a mechanism that requires Rac 
activation, and active GTPase pull-down data indicate Asef2 inhibits Rho 
activation in a Rac-dependent mechanism. It is tempting to extrapolate from this 
that Asef2 regulates adhesion dynamics through a mechanism that requires Rho 
inhibition via Rac activation. Others have shown that Tiam1-mediated Rac 
activation leads to Rho down-regulation, and that some basal level of Rho activity 
is required for normal Rac activation and migration (Sander, ten Klooster et al. 
1999). This relationship between Rac and Rho typically describes a need for Rac 
to not only stimulate protrusion of the leading edge, but to also inhibit Rho from 
causing the formation of stress fibers, which are associated with migration 
inhibition. Previous reports state that Rac is active at the front of the cell while 
Rho is active at the back (Ridley, Schwartz et al. 2003), but this appears not to 
be entirely true. FRET biosensors have shown localized Rac activity leads to a 
decrease in Rho activation at the leading edge of migrating cells (Pertz, Hodgson 
et al. 2006). As a positive regulator of Rac activity and a negative regulator of 
Rho activity that localizes to the leading edge of cells, Asef2 appears to be an 
important regulator of a previously-undescribed mechanism through which Rac 
activation promotes adhesion turnover by inhibiting Rho activity. 
The formation and maturation of cell-matrix adhesions is controlled by Rac 
and Rho, and there has been much debate over the classification of types of 
adhesions. Small nascent adhesions that form within 1 μm of the leading edge 
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help to stabilize new protrusions, and are considered the primary force 
generators in migrating cells (Beningo, Dembo et al. 2001; Nayal, Webb et al. 
2006). They are typically referred to as focal complexes and their formation is 
stimulated by Rac. A second group of larger focal adhesions that are further from 
the leading edge may be important for traction as the cell propels itself forward 
across the ECM, but are associated with slower migration (Petit and Thiery 2000; 
Zaidel-Bar, Ballestrem et al. 2003). It is unclear whether formation of these 
adhesions occurs separately from focal complexes in a Rho-dependent manner, 
or if they are the result of Rho-mediated maturation of focal complexes that 
occurs during the migration process. TIRF images of GFP-Asef2 HT-1080 cells 
show relatively small adhesions that are located primarily at the perimeter of the 
cell and lack larger adhesions further from the cell edge, and fluorescent 
adhesion time-lapse movies indicate adhesions in these cells turn over rapidly 
near the edge. An attractive explanation of Asef2’s role in adhesion turnover is 
that either Asef2 blocks the formation of large, Rho-dependent focal adhesions 
altogether, and/or it prevents the Rho-stimulated maturation of these adhesions 
from small nascent adhesions.  
PI3K and Akt are integral members of the Asef2 pathway regulating 
adhesion dynamics, and this is a novel role for Akt. There are examples in the 
literature of pathways in which PI3K and Akt mediate a down-regulation of Rho, 
but such down-regulation has been associated with stress fiber regulation, not 
adhesion dynamics. For example, the adapter protein, Kank, is a phosphorylation 
target of Akt that is activated downstream of PI3K. Kank phosphorylation leads to 
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its association with 14-3-3, which inhibits Rho in a mechanism that still remains 
unclear; it has been suggested that p190 RhoGAP may mediate Rho inhibition in 
this pathway, as it is a binding partner of 14-3-3. This inhibition decreases stress 
fiber formation in cells and leads to increased cell motility (Kakinuma N 2008). 
The importance of p190A RhoGAP in the regulation of adhesions has recently 
been elucidated in a study that implicated it as an important point of convergence 
for Rho regulation by α5β1 integrins, via tyrosine kinases, and the fibronectin 
receptor, syndecan-4, via PKC. In this mechanism, the integrin pathway activates 
p190A RhoGAP, and the syndecan-4 pathway aids in localization of p190A 
RhoGAP through PKC activation, leading to a localized p190A RhoGAP-
mediated decrease in Rho activation. Integration of these signals regulates 
fibronectin-stimulated formation of vinculin-containing adhesions at the leading 
edge (Bass, Morgan et al. 2008). All together, this makes p190 RhoGAP an 
attractive potential downstream effector of Asef2 that could function as an 
important modulator of adhesion dynamics via Rho inactivation. 
 In addition to p190 RhoGAP, there are several migration and adhesion-
regulating molecules that could be important players in an Asef2 pathway. Future 
studies should include an investigation of kinases such as PAK, FAK, and Src 
that are of known importance for the assembly and disassembly of adhesions as 
well as the process of migration as a whole. The serine/threonine kinase, PAK, is 
a well-established downstream effector of both Cdc42 and Rac that serves many 
roles within the cell. It functions in the lamellipodium to promote protrusion by 
indirectly stimulating cofilin, and it is an important cell-matrix adhesion regulator, 
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where it is a part of a multimolecular complex containing PIX, GIT, and paxillin 
(Zhao, Manser et al. 2000; Delorme, Machacek et al. 2007). Interestingly, PAK 
seems particularly important for adhesion disassembly, although its mechanism 
of action is still unclear (Manser, Huang et al. 1997; Webb, Parsons et al. 2002). 
PAK is targeted to the focal adhesion sites by active Rac or Cdc42, and elevated 
levels of active PAK are associated with diminished focal adhesions, leaving only 
few, small adhesions at the cell periphery as seen by fluorescence microscopy 
(Manser, Huang et al. 1997). This affect on adhesions is very similar to that 
attributed to Asef2 activity as presented in this dissertation. As an activator of 
Cdc42 and Rac that causes a PAK-like adhesion phenotype, it is likely that Asef2 
functions upstream of PAK to regulate adhesion turnover, and this is a promising 
avenue for future research. 
 Like Asef2-knockdown HT-1080 cells, FAK-null mouse keratinocytes 
have atypically large adhesions. Not surprisingly, these adhesions assemble at a 
decreased rate and, also like Asef2-knockdown HT-1080 cells, disassembly of 
adhesions in FAK-null keratinocytes occurs at a further decreased rate (Schober, 
Raghavan et al. 2007).  Interestingly, FAK activity has been correlated to a 
localized decrease in Rho activation and a resulting increase in cell migration, 
spreading, and adhesion turnover (Ren, Kiosses et al. 2000). Additionally, FAK is 
thought to phosphorylate, and therefore activate, p190 RhoGAP at integrin-
enriched focal adhesion sites, where FAK is also known to aid in recruitment of 
other important regulatory molecules, such as Src (Schaller, Hildebrand et al. 
1994; Schober, Raghavan et al. 2007). For all these reasons, the role of FAK in 
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migration and adhesion dynamics regulation is likely to be closely linked to that of 
Asef2, and presents an interesting avenue of future investigation.   
Following FAK autophosphorylation at sites of cell-matrix adhesion, Src 
binding sites are revealed, allowing Src to further activate FAK kinase activity 
while exposing additional protein-binding sites. This FAK-Src complex is able to 
recruit and activate scaffolding molecules that modulate Rac localization and 
activity, leading to protrusion. This complex can also phosphorylate paxillin, 
leading to the recruitment of GIT and PIX, which in turn can be phosphorylated 
by Src (Huveneers and Danen 2009). Like FAK-null cells and Asef2-knockdown 
cells, Src-null fibroblasts exhibit migration and adhesion turnover defects 
(Klinghoffer, Sachsenmaier et al. 1999; Huveneers and Danen 2009). FAK-Src 
signaling promotes adhesion disassembly, and is thought to prevent adhesion 
maturation (Webb, Donais et al. 2004). Interestingly, the FAK-Src complex 
promotes migration by mediating Rho inhibition through p190 RhoGAP in 
response to integrin ligation (Arthur, Petch et al. 2000; Ren, Kiosses et al. 2000; 
Huveneers and Danen 2009).  
Their effects on cell migration, adhesion turnover, and the modulation of 
Rac and Rho activation make PAK, Src, FAK, and p190 RhoGAP likely 
downstream effectors of Asef2. Additionally, the function of Asef2’s regulation by 
APC and the relationship of these two molecules to tumorigenesis and 
metastasis require further study. Further, the impact of Asef2 expression and 
regulation on directed or chemotactic cell migration and the function of Asef2-
mediated Cdc42 activation still remain to be clarified. 
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 Concluding Remarks 
In conclusion, the data presented in this dissertation highlight the 
molecular complexity of cell migration regulation and the importance of its control 
by Rho family GEFs. Asef2 is a recently described GEF that regulates the activity 
of Rac, Rho, and Cdc42 to modulate cell migration. We have employed various 
microscopy techniques to determine Asef2’s function as a promoter of migration 
and specifically as an agent of rapid adhesion turnover. These were 
complemented by biochemical analyses that determined Asef2 functions in a 
Rac-dependent pathway requiring PI3K and Akt to inhibit Rho. Our work has 
elucidated the role of Asef2 in cell migration and uncovered important new roles 
for PI3K and Akt as regulators of adhesion dynamics in a previously-undescribed 
pathway. Dysregulation of Rho family GEFs, such as Asef2, has been linked to 
several human cancers and as a result, our understanding of their function and 
regulation may prove to be the key to development of effective therapeutics in 
the future.       
.            
 124
REFERENCES 
 
 
Abraham, V. C., V. Krishnamurthi, et al. (1999). "The Actin-Based Nanomachine 
at the Leading Edge of Migrating Cells." Biophys. J. 77(3): 1721-1732. 
Aghazadeh, B., W. E. Lowry, et al. (2000). "Structural Basis for Relief of 
Autoinhibition of the Dbl Homology Domain of Proto-Oncogene Vav by 
Tyrosine Phosphorylation." Cell 102(5): 625-633. 
Alexandrova, A. Y., K. Arnold, et al. (2008). "Comparative Dynamics of 
Retrograde Actin Flow and Focal Adhesions: Formation of Nascent 
Adhesions Triggers Transition from Fast to Slow Flow." PLoS ONE 3(9): 
e3234. 
Allen, W. E., D. Zicha, et al. (1998). "A Role for Cdc42 in Macrophage 
Chemotaxis." J. Cell Biol. 141(5): 1147-1157. 
Amann, K. J. and T. D. Pollard (2001). "Direct real-time observation of actin 
filament branching mediated by Arp2/3 complex using total internal 
reflection fluorescence microscopy." Proceedings of the National Academy 
of Sciences of the United States of America 98(26): 15009-15013. 
Arthur, W. T., L. A. Petch, et al. (2000). "Integrin engagement suppresses RhoA 
activity via a c-Src-dependent mechanism." Current Biology 10(12): 719-
722. 
Aspenström, P. (1999). "The Rho GTPases Have Multiple Effects on the Actin 
Cytoskeleton." Experimental Cell Research 246(1): 20-25. 
Bass, M. D., M. R. Morgan, et al. (2008). "p190RhoGAP is the convergence point 
of adhesion signals from {alpha}5{beta}1 integrin and syndecan-4." J. Cell 
Biol. 181(6): 1013-1026. 
Bellacosa, A., C. C. Kumar, et al. (2005). Activation of AKT Kinases in Cancer: 
Implications for Therapeutic Targeting. Advances in Cancer Research, 
Academic Press. Volume 94: 29-86. 
 125
Beningo, K. A., M. Dembo, et al. (2001). "Nascent focal adhesions are 
responsible for the generation of strong propulsive forces in migrating 
fibroblasts." J. Cell Biol. 153(4): 881-888. 
Bi, F., B. Debreceni, et al. (2001). "Autoinhibition Mechanism of Proto-Dbl." Mol. 
Cell. Biol. 21(5): 1463-1474. 
Bishop, A. L. a. A. H. (2000). "Rho GTPases and their effector proteins." 
Biochem. J. 348(2): 241-255. 
Bokoch, G. M. (2003). "BIOLOGY OF THE P21-ACTIVATED KINASES." Annual 
Review of Biochemistry 72(1): 743-781. 
Borisy, G. G. and T. M. Svitkina (2000). "Actin machinery: pushing the envelope." 
Current Opinion in Cell Biology 12(1): 104-112. 
Borm, B., R. P. Requardt, et al. (2005). "Membrane ruffles in cell migration: 
indicators of inefficient lamellipodia adhesion and compartments of actin 
filament reorganization." Experimental Cell Research 302(1): 83-95. 
Broussard, J. A., D. J. Webb, et al. (2008). "Asymmetric focal adhesion 
disassembly in motile cells " Current Opinion in Cell Biology 20(1): 85-90. 
Bryce, N. S., E. S. Clark, et al. (2005). "Cortactin Promotes Cell Motility by 
Enhancing Lamellipodial Persistence." Current Biology 15(14): 1276-1285. 
Burridge, K. and K. Wennerberg (2004). "Rho and Rac Take Center Stage." Cell 
116(2): 167-179. 
Bustos, R. I., M.-A. Forget, et al. (2008). "Coordination of Rho and Rac GTPase 
Function via p190B RhoGAP." Current Biology 18(20): 1606-1611. 
Cain, R. J. and A. J. Ridley (2009). "Phosphoinositide 3-kinases in cell 
migration." Biology of the Cell 101(1): 13-29. 
Carpenter, C. L. and L. C. Cantley (1996). "Phosphoinositide kinases." Current 
Opinion in Cell Biology 8(2): 153-158. 
 126
Carson, M., A. Weber, et al. (1986). "An actin-nucleating activity in 
polymorphonuclear leukocytes is modulated by chemotactic peptides." J. 
Cell Biol. 103(6): 2707-2714. 
Cary, L. A., J. F. Chang, et al. (1996). "Stimulation of cell migration by 
overexpression of focal adhesion kinase and its association with Src and 
Fyn." J Cell Sci 109(7): 1787-1794. 
Cerione, R. A. and Y. Zheng (1996). "The Dbl family of oncogenes." Current 
Opinion in Cell Biology 8(2): 216-222. 
Chan, A. Y., S. J. Coniglio, et al. (2005). "Roles of the Rac1 and Rac3 GTPases 
in human tumor cell invasion." Oncogene 24(53): 7821-7829. 
Chhabra, E. S. and H. N. Higgs (2007). "The many faces of actin: matching 
assembly factors with cellular structures." Nat Cell Biol 9(10): 1110-1121. 
Choi, C. K., M. Vicente-Manzanares, et al. (2008). "Actin and [alpha]-actinin 
orchestrate the assembly and maturation of nascent adhesions in a 
myosin II motor-independent manner." Nat Cell Biol 10(9): 1039-1050. 
Chrzanowska-Wodnicka, M. and K. Burridge (1996). "Rho-stimulated contractility 
drives the formation of stress fibers and focal adhesions." J. Cell Biol. 
133(6): 1403-15. 
Chrzanowska-Wodnicka, M. and K. Burridge (1996). "Rho-stimulated contractility 
drives the formation of stress fibers and focal adhesions." J. Cell Biol. 
133(6): 1403-1415. 
Condeelis, J. (1993). "Life at the Leading Edge: The Formation of Cell 
Protrusions." Annual Review of Cell Biology 9(1): 411-444. 
Couchman, J. R. and D. A. Rees (1979). "The behaviour of fibroblasts migrating 
from chick heart explants: changes in adhesion, locomotion and growth, 
and in the distribution of actomyosin and fibronectin." J. Cell Sci. 39: 149-
65. 
 127
Cox, E. A., S. K. Sastry, et al. (2001). "Integrin-mediated Adhesion Regulates 
Cell Polarity and Membrane Protrusion through the Rho Family of 
GTPases." Mol. Biol. Cell 12(2): 265-277. 
Cross, D. A., D.R. Alessi, P. Cohen, M. Andjelkovich, and B.A. Hemmings 
(1995). "Inhibition of glycogen synthase kinase-3 by insulin mediated by 
protein kinase B 
" Nature 378(6559): 785 - 789  
Czuchra, A., X. Wu, et al. (2005). "Cdc42 Is Not Essential for Filopodium 
Formation, Directed Migration, Cell Polarization, and Mitosis in 
Fibroblastoid Cells." Mol. Biol. Cell 16(10): 4473-4484. 
Das, B., X. Shu, et al. (2000). "Control of Intramolecular Interactions between the 
Pleckstrin Homology and Dbl Homology Domains of Vav and Sos1 
Regulates Rac Binding." J. Biol. Chem. 275(20): 15074-15081. 
Deakin, N. O. and C. E. Turner (2008). "Paxillin comes of age." J Cell Sci 
121(15): 2435-2444. 
Degtyarev, M., A. De Maziere, et al. (2008). "Akt inhibition promotes autophagy 
and sensitizes PTEN-null tumors to lysosomotropic agents." J. Cell Biol. 
183(1): 101-16. 
Delorme, V., M. Machacek, et al. (2007). "Cofilin Activity Downstream of Pak1 
Regulates Cell Protrusion Efficiency by Organizing Lamellipodium and 
Lamella Actin Networks." Developmental Cell 13(5): 646-662. 
Estrach, S., S. Schmidt, et al. (2002). "The Human Rho-GEF Trio and Its Target 
GTPase RhoG Are Involved in the NGF Pathway, Leading to Neurite 
Outgrowth." Current Biology 12(4): 307-312. 
Etienne-Manneville, S. (2004). "Cdc42 - the centre of polarity." J Cell Sci 117(8): 
1291-1300. 
Etienne-Manneville, S. and A. Hall (2003). "Cdc42 regulates GSK-3beta and 
adenomatous polyposis coli to control cell polarity." Nature 421(6924): 
753-6. 
 128
Faix, J. and K. Rottner (2006). "The making of filopodia." Current Opinion in Cell 
Biology 18(1): 18-25. 
Fenteany, G. a. G., M. (2003). "Cytoskeletal remodeling in leukocyte function." 
Curr Opin Hematol 11: 15-24. 
Franco, S. J., M. A. Rodgers, et al. (2004). "Calpain-mediated proteolysis of talin 
regulates adhesion dynamics." Nat Cell Biol 6(10): 977-983. 
Franke, T. F., S.-I. Yang, et al. (1995). "The protein kinase encoded by the Akt 
proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-
kinase." Cell 81(5): 727-736. 
Hall, A. (1994). "Small GTP-Binding Proteins and the Regulation of the Actin 
Cytoskeleton." Annual Review of Cell Biology 10(1): 31-54. 
Hall, A. (1998). "Rho GTPases and the Actin Cytoskeleton." Science 279(5350): 
509-514. 
Hamann, M. J., C. M. Lubking, et al. (2007). "Asef2 Functions as a Cdc42 
Exchange Factor and Is Stimulated by the Release of an Autoinhibitory 
Module from a Concealed C-Terminal Activation Element." Mol. Cell. Biol. 
27(4): 1380-1393. 
Harvey, K., I. C. Duguid, et al. (2004). "The GDP-GTP Exchange Factor 
Collybistin: An Essential Determinant of Neuronal Gephyrin Clustering." J. 
Neurosci. 24(25): 5816-5826. 
Hawkins, P. T., A. Eguinoa, et al. (1995). "PDGF stimulates an increase in GTP-
Rac via activation of phosphoinositide 3-kinase." Current Biology 5(4): 
393-403. 
Hooshmand-Rad, R., L. Claesson-Welsh, et al. (1997). "Involvement of 
Phosphatidylinositide 3'-Kinase and Rac in Platelet-Derived Growth 
Factor-Induced Actin Reorganization and Chemotaxis." Experimental Cell 
Research 234(2): 434-441. 
Horwitz, A. R. and J. T. Parsons (1999). "CELL BIOLOGY:Cell Migration--Movin' 
On." Science 286(5442): 1102-1103. 
 129
Hotchin, N. A. and A. Hall (1995). "The assembly of integrin adhesion complexes 
requires both extracellular matrix and intracellular rho/rac GTPases." J. 
Cell Biol. 131(6): 1857-1865. 
Huveneers, S. and E. H. J. Danen (2009). "Adhesion signaling - crosstalk 
between integrins, Src and Rho." J Cell Sci 122(8): 1059-1069. 
Irie, H. Y., R. V. Pearline, et al. (2005). "Distinct roles of Akt1 and Akt2 in 
regulating cell migration and epithelial-mesenchymal transition." J. Cell 
Biol. 171(6): 1023-1034. 
Itoh, R. E., E. Kiyokawa, et al. (2008). "Phosphorylation and activation of the 
Rac1 and Cdc42 GEF Asef in A431 cells stimulated by EGF." J Cell Sci 
121(16): 2635-2642. 
Jaffe, A. B., A. Hall, et al. (2005). "Association of CNK1 with Rho Guanine 
Nucleotide Exchange Factors Controls Signaling Specificity Downstream 
of Rho." Current Biology 15(5): 405-412. 
Kaibuchi, K., S. Kuroda, et al. (1999). "REGULATION OF THE CYTOSKELETON 
AND CELL ADHESION BY THE RHO FAMILY GTPASES IN 
MAMMALIAN CELLS." Annual Review of Biochemistry 68(1): 459-486. 
Kakinuma N, R. B., Zhu Y, Wang Y, Kiyama R. (2008). "Kank regulates RhoA-
dependent formation of actin stress fibers and cell migration via 14-3-3 in 
PI3K-Akt signaling." J Cell Biol. 181(3): 537-49. 
Karnoub AE, W. D., Rossman KL, Pruitt WM, Campbell SL, Sondek J, Der CJ. 
(2001). "Molecular basis for Rac1 recognition by guanine nucleotide 
exchange factors." Nat Struct Biol. 8(12): 1037-1041. 
Katome, T., T. Obata, et al. (2003). "Use of RNA interference-mediated gene 
silencing and adenoviral overexpression to elucidate the roles of 
AKT/protein kinase B isoforms in insulin actions." J. Biol. Chem. 278(30): 
28312-23. 
Kawasaki, Y., M. Sagara, et al. (2007). "Identification and characterization of 
Asef2, a guanine-nucleotide exchange factor specific for Rac1 and 
Cdc42." Oncogene 26(55): 7620-267. 
 130
Kawasaki, Y., M. Sagara, et al. (2007). "Identification and characterization of 
Asef2, a guanine-nucleotide exchange factor specific for Rac1 and 
Cdc42." Oncogene 26(55): 7620-7267. 
Kawasaki, Y., T. Senda, et al. (2000). "Asef, a Link Between the Tumor 
Suppressor APC and G-Protein Signaling." Science 289(5482): 1194-
1197. 
Kawasaki, Y., S. Tsuji, et al. (2009). "Adenomatous Polyposis Coli and Asef 
Function Downstream of Hepatocyte Growth Factor and 
Phosphatidylinositol 3-Kinase." J. Biol. Chem. 284(33): 22436-22443. 
Kim, D., S. Kim, et al. (2001). "Akt/PKB promotes cancer cell invasion via 
increased motility and metalloproteinase production." FASEB J. 15(11): 
1953-1962. 
Kins, S., H. Betz, et al. (2000). "Collybistin, a newly identified brain-specific GEF, 
induces submembrane clustering of gephyrin." Nat Neurosci 3(1): 22-29. 
Klinghoffer, R. A., C. Sachsenmaier, et al. (1999). "Src family kinases are 
required for integrin but not PDGFR signal transduction." EMBO J 18(9): 
2459-2471. 
Kozma, R., S. Ahmed, et al. (1995). "The Ras-related protein Cdc42Hs and 
bradykinin promote formation of peripheral actin microspikes and filopodia 
in Swiss 3T3 fibroblasts." Mol. Cell. Biol. 15(4): 1942-1952. 
Kraynov, V. S., C. Chamberlain, et al. (2000). "Localized Rac Activation 
Dynamics Visualized in Living Cells." Science 290(5490): 333-337. 
Kubiseski, T. J., J. Culotti, et al. (2003). "Functional Analysis of the 
Caenorhabditis elegans UNC-73B PH Domain Demonstrates a Role in 
Activation of the Rac GTPase In Vitro and Axon Guidance In Vivo." Mol. 
Cell. Biol. 23(19): 6823-6835. 
Larue, L. and A. Bellacosa (2005). "Epithelial-mesenchymal transition in 
development and cancer: role of phosphatidylinositol 3[prime] kinase//AKT 
pathways." Oncogene 24(50): 7443-7454. 
 131
Lauffenburger, D. A. and A. F. Horwitz (1996). "Cell Migration: A Physically 
Integrated Molecular Process." Cell 84(3): 359-369. 
Laukaitis, C. M., D. J. Webb, et al. (2001). "Differential Dynamics of {alpha}5 
Integrin, Paxillin, and {alpha}-Actinin during Formation and Disassembly of 
Adhesions in Migrating Cells." J. Cell Biol. 153(7): 1427-1440. 
Lee, J. and K. Jacobson (1997). "The composition and dynamics of cell-
substratum adhesions in locomoting fish keratocytes." J Cell Sci 110(22): 
2833-2844. 
Lim, Y., S.-T. Lim, et al. (2008). "PyK2 and FAK connections to p190Rho guanine 
nucleotide exchange factor regulate RhoA activity, focal adhesion 
formation, and cell motility." J. Cell Biol. 180(1): 187-203. 
Lin, Q., W. Yang, et al. (2006). "Identification of a DOCK180-related guanine 
nucleotide exchange factor that is capable of mediating a positive 
feedback activation of Cdc42." J. Biol. Chem. 281(46): 35253-62. 
llic, D. k., Y. Furuta, et al. (1995). "Reduced cell motility and enhanced focal 
adhesion contact formation in cells from FAK-deficient mice." Nature 
377(6549): 539-544. 
Lodish, H., A. Berk, et al. (2000). "Molecular Cell Biology, 4e." WHFreeman and 
Company. 
Lorenzi MV, C. P., Chen Q, Hori Y, Miki T. (1999). "Distinct expression patterns 
and transforming properties of multiple isoforms of Ost, an exchange 
factor for RhoA and Cdc42." Oncogene 18(33): 4742-55. 
Manser, E., H. Y. Huang, et al. (1997). "Expression of constitutively active alpha-
PAK reveals effects of the kinase on actin and focal complexes." Mol. Cell. 
Biol. 17(3): 1129-1143. 
Manser, E., T.-H. Loo, et al. (1998). "PAK Kinases Are Directly Coupled to the 
PIX Family of Nucleotide Exchange Factors." Molecular Cell 1(2): 183-
192. 
 132
Mayhew, M. W., D. J. Webb, et al. (2006). "Identification of Protein Networks 
Associated with the 
PAK1&#x2212;&#x03B2;PIX&#x2212;GIT1&#x2212;Paxillin Signaling 
Complex by Mass Spectrometry." Journal of Proteome Research 5(9): 
2417-2423. 
Mitin, N., L. Betts, et al. (2007). "Release of autoinhibition of ASEF by APC leads 
to CDC42 activation and tumor suppression." Nat Struct Mol Biol 14(9): 
814-823. 
Miyamoto, S., H. Teramoto, et al. (1995). "Integrin function: molecular hierarchies 
of cytoskeletal and signaling molecules." J. Cell Biol. 131(3): 791-805. 
Murayama, K., M. Shirouzu, et al. (2007). "Crystal Structure of the Rac Activator, 
Asef, Reveals Its Autoinhibitory Mechanism." J. Biol. Chem. 282(7): 4238-
4242. 
Nayal, A., D. J. Webb, et al. (2006). "Paxillin phosphorylation at Ser273 localizes 
a GIT1-PIX-PAK complex and regulates adhesion and protrusion 
dynamics." J. Cell Biol. 173(4): 587-589. 
Nimnual, A. S., L. J. Taylor, et al. (2003). "Redox-dependent downregulation of 
Rho by Rac." Nat Cell Biol 5(3): 236-241. 
Nobes, C. D. and A. Hall (1995). "Rho, Rac, and Cdc42 GTPases regulate the 
assembly of multimolecular focal complexes associated with actin stress 
fibers, lamellipodia, and filopodia." Cell 81(1): 53-62. 
Oikawa, T., H. Yamaguchi, et al. (2004). "PtdIns(3,4,5)P3 binding is necessary 
for WAVE2-induced formation of lamellipodia." Nat Cell Biol 6(5): 420-426. 
Palecek, S. P., A. Huttenlocher, et al. (1998). "Physical and biochemical 
regulation of integrin release during rear detachment of migrating cells." J 
Cell Sci 111(7): 929-940. 
Papadopoulos, T., V. Eulenburg, et al. (2008). "Collybistin is required for both the 
formation and maintenance of GABAergic postsynapses in the 
hippocampus." Molecular and Cellular Neuroscience 39(2): 161-169. 
 133
Pelish, H. E., J. R. Peterson, et al. (2006). "Secramine inhibits Cdc42-dependent 
functions in cells and Cdc42 activation in vitro." Nat. Chem. Biol. 2(1): 39-
46. 
Pertz, O., L. Hodgson, et al. (2006). "Spatiotemporal dynamics of RhoA activity in 
migrating cells." Nature 440(7087): 1069-1072. 
Petit, V. and J.-P. Thiery (2000). "Focal adhesions: structure and dynamics." 
Biology of the Cell 92(7): 477-494. 
Pollard, T. D., L. Blanchoin, et al. (2000). "MOLECULAR MECHANISMS 
CONTROLLING ACTIN FILAMENT DYNAMICS IN NONMUSCLE 
CELLS." Annual Review of Biophysics and Biomolecular Structure 29(1): 
545. 
Pollard, T. D. and G. G. Borisy (2003). "Cellular Motility Driven by Assembly and 
Disassembly of Actin Filaments." Cell 112(4): 453-465. 
Ponti, A., M. Machacek, et al. (2004). "Two distinct actin networks drive the 
protrusion of migrating cells." Science 305(5691): 1782-6. 
Rameh, L. E., A.-k. Arvidsson, et al. (1997). "A Comparative Analysis of the 
Phosphoinositide Binding Specificity of Pleckstrin Homology Domains." J. 
Biol. Chem. 272(35): 22059-22066. 
Ren, X. D., W. B. Kiosses, et al. (2000). "Focal adhesion kinase suppresses Rho 
activity to promote focal adhesion turnover." J Cell Sci 113(20): 3673-
3678. 
Ren, X. D., W.B. Kiosses, and M.A. Schwartz. (1999). "Regulation of the small 
GTP-binding protein Rho by cell adhesion and the cytoskeleton." EMBO 
J.(18): 578-85. 
Ridley, A. J. (2001). "Rho GTPases and cell migration." J Cell Sci 114(15): 2713-
2722. 
Ridley, A. J. and A. Hall (1992). "The small GTP-binding protein rho regulates the 
assembly of focal adhesions and actin stress fibers in response to growth 
factors." Cell 70(3): 389-399. 
 134
Ridley, A. J., M. A. Schwartz, et al. (2003). "Cell Migration: Integrating Signals 
from Front to Back." Science 302(5651): 1704-1709. 
Rossman, K. L., C. J. Der, et al. (2005). "GEF means go: turning on RHO 
GTPases with guanine nucleotide-exchange factors." Nat Rev Mol Cell 
Biol 6(2): 167-180. 
Rottner, K., A. Hall, et al. (1999). "Interplay between Rac and Rho in the control 
of substrate contact dynamics." Current Biology 9(12): 640-649. 
Russo, C., Y. Gao, et al. (2001). "Modulation of Oncogenic DBL Activity by 
Phosphoinositol Phosphate Binding to Pleckstrin Homology Domain." J. 
Biol. Chem. 276(22): 19524-19531. 
Sagara, M., Y. Kawasaki, et al. (2009). "Asef2 and Neurabin2 cooperatively 
regulate actin cytoskeletal organization and are involved in HGF-induced 
cell migration." Oncogene. 
Sagara, M., Y. Kawasaki, et al. (2009). "Asef2 and Neurabin2 cooperatively 
regulate actin cytoskeletal organization and are involved in HGF-induced 
cell migration." Oncogene 28(10): 1357-1365. 
Sander, E. E., J. P. ten Klooster, et al. (1999). "Rac Downregulates Rho Activity: 
Reciprocal Balance between Both GTPases Determines Cellular 
Morphology and Migratory Behavior." J. Cell Biol. 147(5): 1009-1022. 
Schaller, M. D., J. D. Hildebrand, et al. (1994). "Autophosphorylation of the focal 
adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src." 
Mol. Cell. Biol. 14(3): 1680-1688. 
Schiller, M. R., K. Chakrabarti, et al. (2006). "Regulation of RhoGEF Activity by 
Intramolecular and Intermolecular SH3 Domain Interactions." J. Biol. 
Chem. 281(27): 18774-18786. 
Schmidt, A. and A. Hall (2002). "Guanine nucleotide exchange factors for Rho 
GTPases: turning on the switch." Genes & Development 16(13): 1587-
1609. 
 135
Schober, M., S. Raghavan, et al. (2007). "Focal adhesion kinase modulates 
tension signaling to control actin and focal adhesion dynamics." J. Cell 
Biol. 176(5): 667-680. 
Sjoblom, T., S. Jones, et al. (2006). "The Consensus Coding Sequences of 
Human Breast and Colorectal Cancers." Science 314(5797): 268-274. 
Srinivasan, S., F. Wang, et al. (2003). "Rac and Cdc42 play distinct roles in 
regulating PI(3,4,5)P3 and polarity during neutrophil chemotaxis." J. Cell 
Biol. 160(3): 375-385. 
Steffen, A., J. Faix, et al. (2006). "Filopodia Formation in the Absence of 
Functional WAVE- and Arp2/3-Complexes." Mol. Biol. Cell 17(6): 2581-
2591. 
Tilghman, R. W., J. K. Slack-Davis, et al. (2005). "Focal adhesion kinase is 
required for the spatial organization of the leading edge in migrating cells." 
J Cell Sci 118(12): 2613-2623. 
Tolias, K. F., L. C. Cantley, et al. (1995). "Rho Family GTPases Bind to 
Phosphoinositide Kinases." J. Biol. Chem. 270(30): 17656-17659. 
Turner, C. E., M. C. Brown, et al. (1999). "Paxillin LD4 Motif Binds PAK and PIX 
through a Novel 95-kD Ankyrin Repeat, ARF-GAP Protein: A Role in 
Cytoskeletal Remodeling." J. Cell Biol. 145(4): 851-863. 
Turner, C. E., J. R. Glenney, Jr., et al. (1990). "Paxillin: a new vinculin-binding 
protein present in focal adhesions." J. Cell Biol. 111(3): 1059-1068. 
Uehata, M., T. Ishizaki, et al. (1997). "Calcium sensitization of smooth muscle 
mediated by a Rho-associated protein kinase in hypertension." Nature 
389(6654): 990-4. 
Wang, Y. L. (1985). "Exchange of actin subunits at the leading edge of living 
fibroblasts: possible role of treadmilling." J. Cell Biol. 101(2): 597-602. 
Weaver, A. M., M. E. Young, et al. (2003). "Integration of signals to the Arp2/3 
complex." Current Opinion in Cell Biology 15(1): 23-30. 
 136
Webb, D. J., K. Donais, et al. (2004). "FAK-Src signalling through paxillin, ERK 
and MLCK regulates adhesion disassembly." Nat Cell Biol 6(2): 154-161. 
Webb, D. J., J. T. Parsons, et al. (2002). "Adhesion assembly, disassembly and 
turnover in migrating cells - over and over and over again." Nat Cell Biol 
4(4): E97-E100. 
Wegner, A. M., C. A. Nebhan, et al. (2008). "N-WASP and the Arp2/3 Complex 
Are Critical Regulators of Actin in the Development of Dendritic Spines 
and Synapses." J. Biol. Chem. 283(23): 15912-15920. 
Welch, H. C. E., W. J. Coadwell, et al. (2002). "P-Rex1, a PtdIns(3,4,5)P3- and 
G[beta][gamma]-Regulated Guanine-Nucleotide Exchange Factor for 
Rac." Cell 108(6): 809-821. 
Welch, H. C. E., W. J. Coadwell, et al. (2003). "Phosphoinositide 3-kinase-
dependent activation of Rac." FEBS Letters 546(1): 93-97. 
Wymann, M., Bulgarelli-Leva, G, Zvelebil, MJ, Pirola, L, Vanhaesebroeck, B, 
Waterfield, MD, Panayotou, G (1996). "Wortmannin inactivates 
phosphoinositide 3-kinase by covalent modification of Lys-802, a residue 
involved in the phosphate transfer reaction." Mol. Cell. Biol. 16: 1722-1733  
Xiang, S., E. Y. Kim, et al. (2006). "The Crystal Structure of Cdc42 in Complex 
with Collybistin II, a Gephyrin-interacting Guanine Nucleotide Exchange 
Factor." Journal of Molecular Biology 359(1): 35-46. 
Xu B, P. H., Kirchhausen T, Hammond GB. (2006). "Large scale synthesis of the 
Cdc42 inhibitor secramine A and its inhibition of cell spreading." Org 
Biomol Chem. 4(22): 4149-57. 
Yang, L., L. Wang, et al. (2006). "Gene Targeting of Cdc42 and Cdc42GAP 
Affirms the Critical Involvement of Cdc42 in Filopodia Induction, Directed 
Migration, and Proliferation in Primary Mouse Embryonic Fibroblasts." Mol. 
Biol. Cell 17(11): 4675-4685. 
Yang, Z.-Z., O. Tschopp, et al. (2003). "Protein Kinase B{alpha}/Akt1 Regulates 
Placental Development and Fetal Growth." J. Biol. Chem. 278(34): 32124-
32131. 
 137
Yin, H. L. and P. A. Janmey (2003). "PHOSPHOINOSITIDE REGULATION OF 
THE ACTIN CYTOSKELETON." Annual Review of Physiology 65(1): 761-
789. 
Yuruker, B. and V. Niggli (1992). "Alpha-actinin and vinculin in human 
neutrophils: reorganization during adhesion and relation to the actin 
network." J Cell Sci 101(2): 403-414. 
Zaidel-Bar, R., C. Ballestrem, et al. (2003). "Early molecular events in the 
assembly of matrix adhesions at the leading edge of migrating cells." J 
Cell Sci 116(22): 4605-4613. 
Zaidel-Bar, R., R. Milo, et al. (2007). "A paxillin tyrosine phosphorylation switch 
regulates the assembly and form of cell-matrix adhesions." J Cell Sci 
120(1): 137-148. 
Zhang, H. and I. G. Macara (2008). "The PAR-6 Polarity Protein Regulates 
Dendritic Spine Morphogenesis through p190 RhoGAP and the Rho 
GTPase." Developmental Cell 14(2): 216-226. 
Zhao, Z.-s., E. Manser, et al. (2000). "Coupling of PAK-Interacting Exchange 
Factor PIX to GIT1 Promotes Focal Complex Disassembly." Mol. Cell. 
Biol. 20(17): 6354-6363. 
Zhou, G. L., D. F. Tucker, et al. (2006). "Opposing roles for Akt1 and Akt2 in 
Rac/Pak signaling and cell migration." J. Biol. Chem. 281(47): 36443-53. 
Zigmond, S. H. (1996). "Signal transduction and actin filament organization." 
Current Opinion in Cell Biology 8(1): 66-73. 
 
 
 138
